EP0756461A1 - Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same - Google Patents

Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same

Info

Publication number
EP0756461A1
EP0756461A1 EP95917934A EP95917934A EP0756461A1 EP 0756461 A1 EP0756461 A1 EP 0756461A1 EP 95917934 A EP95917934 A EP 95917934A EP 95917934 A EP95917934 A EP 95917934A EP 0756461 A1 EP0756461 A1 EP 0756461A1
Authority
EP
European Patent Office
Prior art keywords
product according
filter
tobacco
smokable
smokable product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95917934A
Other languages
German (de)
French (fr)
Other versions
EP0756461B1 (en
Inventor
Reiner Kopsch
Wolfram Röper
Wolfgang Wildenau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HF and PhF Reemtsma GmbH and Co
Original Assignee
HF and PhF Reemtsma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6517522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0756461(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by HF and PhF Reemtsma GmbH and Co filed Critical HF and PhF Reemtsma GmbH and Co
Priority to SI9530458T priority Critical patent/SI0756461T1/en
Publication of EP0756461A1 publication Critical patent/EP0756461A1/en
Application granted granted Critical
Publication of EP0756461B1 publication Critical patent/EP0756461B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/301Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24DCIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
    • A24D3/06Use of materials for tobacco smoke filters
    • A24D3/14Use of materials for tobacco smoke filters of organic materials as additive

Definitions

  • the present invention relates to tobacco products or tobacco-like products which are provided with known antioxidative natural substances and / or nature-identical synthesis products thereof and are intended for smoking, and to processes for producing these products.
  • the human organism is exposed to a naturally occurring basic load of toxic substances and is therefore confronted with a large number of utagenic and carcinogenic substances, some of which are formed by itself through its own metabolism.
  • the body's defense system is of particular importance, which can also be influenced individually by the way of life.
  • the food intake in the body causes a number of chemical reactions, whereby mutagenic and antimutagenic substances are in close interrelation.
  • tobacco products used in this description includes both cigarettes, cigarillos and tobacco cartridges (so-called plug-in cigarettes) with or without a filter, as well as fine cut and pipe tobacco, which consist entirely or in part of tobacco and / or another smokable material, as well as tobacco candles similar tobacco products such as "Kretek” - cigaret:; ⁇ with the addition of up to 50% by weight of smokable spices, or to understand pure, tobacco-free plant cigarettes.
  • the object of the present invention is therefore to create a further smoking article which contains additives which further reduce the potential risks of smoking, and to provide a method for producing such smoking articles.
  • a smokable product made from tobacco and / or another smokable material which comprises antioxidative natural substances and / or nature-identical synthesis products thereof, which are selected from:
  • the smokable product according to the invention has a significantly lower risk potential than conventional products.
  • the hydroxycinnamic acids p-cumaric acid, caffeic acid and ferulic acid are preferred.
  • the preferred esters of hydroxycinnamic acids are their methyl and ethyl esters, while the preferred deposits of hydroxycinnamic acids consist of their compounds with fruit acids or quinic acid, of which chlorogenic acids are particularly preferred.
  • the plant phenols derivable from hydroxycinnamic acids umbelliferone, aesculetin, scopoletin, curcumin, ellagic acid and dihydrocaffeic acid are preferred, while the polymers of the hydroxycinnamic alcohols are preferably derived from p-coumaryl alcohol, coniferyl alcohol and sinapyl alcohol.
  • the other natural substances of plant origin with both anti-mutagenic and flavoring properties are preferably vanillin, ethylvanillin, cinnamaldehyde, anisaldehyde, coumarin, 6-methylcoumarin, eugenol, jasmine aldehyde, anethole, p-anisylacetone, limonene, cinnamon and cinnamon extract.
  • the antioxidative vitamins combined according to the invention with these other natural substances of plant origin are preferably ascorbic acid, ⁇ -carotene, retinol and tocopherol and their derivatives, optionally in combination with one another and / or other vitamins.
  • Stable derivatives of ascorbic acid such as ascorbic acid palmitate or ascorbigen (ascorbic acid bound O 95/28098 PC ⁇ 7EP95 / 01452
  • vitamins which have an antioxidative effect and are complexed with eukaryotic cell cultures, ⁇ -carotene, retinol and ⁇ -tocopherol and their derivatives are preferred.
  • the preferred hydroxycinnamic alcohols according to the invention are p-comaryl alcohol, coniferyl alcohol and sinapyl alcohol and form the lignin which occurs in woody plants.
  • the various hydroxycinnamic alcohols are incorporated into macromolecules in varying amounts in various forms of linkage.
  • the strength of the wood is essentially caused by the incorporation of lignin in cellulose.
  • the antioxidative natural substances and / or nature-identical synthesis products thereof are contained in the tobacco product individually or in combination, their relative amounts based on the total weight being able to vary depending on the intended component or components of a smokable tobacco product.
  • the natural substances can be incorporated or upgraded in a known manner both in the smoking tobacco including the conventional additives and in individual components of the tobacco products that are accessible to the mainstream smoke, such as filters, wrapping papers, carrier substances, Na glue, etc. Manufacturer of the tobacco product can also happen proportionately with its suppliers. If the pure natural substances are added to tobacco, their preferred relative use amount is in the range of 0.1 per thousand to 25% by weight, a content between 1 and 5% by weight being particularly preferred.
  • the preferred amounts are 0.1 to 50% by weight, with amounts of 1 to 20% by weight being particularly preferred are.
  • the filter used can be a chamber filter, a cellulose acetate filter or a cellulose random-fiber fleece filter or a multiple filter, preferably a double filter (in each case with or without filter ventilation), the double filter having a higher line-side draw resistance and a lower mouth-side draw resistance and an overall filter efficiency of 80 - 99%. Filters made from other filter materials known per se can also be used in combination with the antioxidative natural substances.
  • Natural substances according to the invention also apply to the preferred amounts of 0.1 per mille to 25% by weight, based on the pure natural substances, and also the particularly preferred amounts of use of 1.0 to 5% by weight, in all cases the intended use can be supplemented by adding the pure natural substances or the pure substances according to the invention to the smokable mixture.
  • a further preferred use or offer form of the natural material containing the antioxidative natural substances, in particular vitamins such as ⁇ -tocopherol or ⁇ -carotene, are cultured eukaryotic cells, the dry matter of which is between 0.5 and 15% by weight of the antioxidant vitamins in fixed or fixed form May contain, such as specially cultivated tobacco or yeast cells.
  • the antioxidative natural substances according to the invention firmly attach themselves to the cultured eukaryotic cells when they are added to the culture broth in suitable concentrations.
  • concentrations in the case of ⁇ -tocopherol are 0.01 to 10, preferably 0.05 to 2% by volume, and in the case of ⁇ -carotene 0, 01 to 0.5, preferably 0.05 to 0.2 vol .-% o.
  • the complexes according to the invention thus formed can then be added after filtration from the culture broth and drying of the smokable mixture.
  • the substances according to the invention when producing a smokable mixture, can be added to the leaf cut and / or the rib cut in a manner known per se, if appropriate using known adhesives and binders.
  • the substances can be incorporated into film or tape tobacco in a known manner, which is particularly useful when using solid, ground natural substances.
  • a novel, non-tobacco-containing plant film can also be used here, which at least partially contains the natural substances according to the invention in the form of plant-specific ingredients of parts of the plant film material.
  • the smokable base material is preferably a mixture of lamina tobacco or a mixture of lamina tobacco and foil tobacco or a tobacco-free mixture of plant material which is made from coltsfoot, peppermint, nettle, white plantain, spearmint, lavender, thyme, Sweet or sour cherry leaves, knotweed leaves, rose leaves, allspice leaves or cinnamon bark are derived.
  • the smokable material be a combination of tobacco blend and tobacco-free blend.
  • the substances according to the invention can be added to the casing and / or flavoring substances in liquid form, and they can even replace them.
  • the usual filter systems essentially consist either of a filter fiber tow made of cellulose acetate fibers or of cellulose fibers which are matted together, which result in a cellulose random fiber fleece.
  • the filter fiber tow is normally sprayed with one of the permitted hardeners during the manufacture of the cigarette filter in order to crosslink the fibers and thus harden the filter.
  • These hardeners mostly consist of triacetin or.
  • Triethylene glycol diacetate (TEGDA) can, according to the invention, be partly or completely replaced by the natural substances according to the invention in liquid form, provided that they dissolve in the hardener or act as hardeners themselves, for example eugenol.
  • Suspensions of solid natural substances can also be used in the hardener, but also scattering of ground natural substances in filter fiber tow made of cellulose acetate fibers.
  • the substance eugenol can also be used in the form of a mixture with other substances listed in Tables 2 and 3 as hardeners or solvents, the specific mixtures and their respective proportions taking into account their properties and their market prices and depending on the or components of the product according to the invention to be treated can easily be selected.
  • a mixture of 80 parts of triacetin, 15 parts of eugenol and 5 parts of ⁇ -tocopherol acetate is particularly preferred.
  • the substances mixed in this ratio result in a clear solution, from which triacetin and eugenol preferably diffuse into the interior of the fibers after application to cellulose acetate fibers, as a result of which the tocopherol acetate is enriched on the surface of the filter fibers, and thus particularly easily from here as an emitter acting "filter" can be transferred into the main stream smoke.
  • the filter to be used in the process for producing a tobacco product does not consist of cellulose acetate fibers, it and / or the other components of the later product such as the smokable tobacco-containing or tobacco-free vegetable material
  • the cigarette paper and the suture to be used according to the invention are provided with a Solution from the aromatic substances and vitamins (or provitamins) treated according to the invention, individual representatives of these groups of substances being usable as solvents.
  • the respective solubilities and miscibilities of the entire substances in or with some of the natural substances which can also be used as solvents according to the invention are shown in Table 3.
  • TEGDA triethylene glycol diacetate
  • ⁇ 1 solubility less than 1% by weight
  • the substances according to the invention can already be incorporated into the fleece by the filter material manufacturer.
  • the usually bleached cellulose fibers of, for example, annual plants of the known random fiber fleece can be exchanged partially or predominantly, preferably up to 85%, with suitable unbleached wood pulp "fibers" containing lignin with sufficient antioxidant activity.
  • the solid substances according to the invention can be introduced into the chambers of chamber filters, for example in granular form with a grain diameter of about 0.8 mm, by the filter rod manufacturer, as can liquid substances according to the invention, taken up, for example, from wood flour or lignin granules, with particularly suitable or wood particles in fiber-dust or granule form containing a lot of antioxidative action can also be used as solitary as chamber embedding materials or as self-supporting, porous or smoke-permeable compacts in the desired filter format.
  • the inside of the filter wrapping paper that comes into contact with the mainstream smoke when it is smoking can also be coated with the natural substances according to the invention.
  • the cigarettes paper can be provided with the natural substances according to the invention in encapsulated or unencapsulated form in a manner known per se, both single-layer and two-layer cigarette papers being suitable for this.
  • the inner tobacco rod wrapper which can also be network-like or highly porous (10-20,000 CORESTA), is preferably provided with the substances according to the invention.
  • This net-like inner tobacco rod wrapping can be made predominantly or entirely from suitable wood pulp containing lignin which has an antioxidative effect, and the fiber content of otherwise customary cigarette papers can also consist at least partly of suitable unbleached wood pulp containing lignin.
  • the glue used in the area of the cigarette seam to glue the tobacco rod casing can also contain the natural substances according to the invention in liquid or finely ground form. It has been shown here that the technical properties of glues treated in this way can even be improved.
  • the tobacco product according to the invention when consumed or smoked, its mainstream smoke is enriched with the natural substances known to have an antioxidative effect, with the result that the antimutagenic substances released by the mainstream smoke are approximately at the same time as the potential pollutants of the mainstream smoke are available to the organism at the site of metabolism and thus a possible mutagenic effect of the undesirable critical substances is largely largely compensated.
  • test principle essentially consists in the fact that histidine-auxotrophic (his " ) indicator bacteria of the Salmonella tvphimurium species mutate back into their prototrophic form (his + ) under the influence of mutagenic substances. Carrying out the Arnes test without or With “S 9 activation", a statement can be made as to whether a test substance is mutagenic in its initial form or only after metabolism.
  • the tobacco product proposed according to the invention has a greatly reduced risk compared to conventional products. potential, since the natural substances used exert their antioxidative properties on a large number of undesirable substances and their effects develop at the point of metabolism.
  • the 48 mg heavy cigarette paper had a porosity of 24 coresta, the filter weight was around 180 mg, the filter material consisted of commercially available cellulose acetate fibers (3.0 Y / 35000), the hardener was triacetin (approx. 7%).
  • Scopoletin (7-hydroxy-6-methoxycoumarin) with a melting point of 205 ° C, without boiling point, is contained as a natural plant substance in virginia tobacco in a concentration of about 300 ppm.
  • three versions of experimental cigarettes were produced on the basis of the same lot of cigarettes as in Example 1.
  • the tobacco of 60 filter cigarettes according to Example 1 was blown out of these using compressed air, collected, divided into thirds, two thirds of the natural product (compared only with ethanol) and in 60 equal proportions the blown out, in three Loose divided 3 x 20 filter sleeves were added again using a commercially available tobacco tamping machine for filter cigarette tubes, although the strand weight of the filter cigarettes produced in this way decreased slightly.
  • the concentration of scopoletin in the tobacco was increased by spraying an ethanolic solution of scopoletin on the cigarette tobacco from the original 330 ppm to 630 ppm and 5,330 ppm, respectively.
  • the manufactured cigarettes were smoked as described in Example 1, the smoke condensate collected being dissolved in methanol.
  • the filter sleeve design data corresponded to that of Example 1, the strand weight decreased to 930 ⁇ 20 mg, the amount of tobacco smoked was 785 mg.
  • the analytical determination of scopoletin was carried out using HPL under the following conditions:
  • Plasticizer water / methanol / acetic acid - 85/13/2
  • Smoked amount of tobacco 785 mg per cigarette
  • Amount of eugenol. * ⁇ '% Tr. Percent by weight, based on the dry weight.
  • test cigarettes were smoked under standard conditions (see example 1).
  • the test results are shown graphically in FIG.
  • the mutagenicity of the smoke condensate of mixture 1 was reduced to 55.5% of the effect of the comparison, which can be explained by the amount of eugenol contained in the cloves.
  • the cloves used had an eugenol content of 17.0%.
  • the surprising reduction in mutagenicity can of the smoke condensate of mixture 2 to 65.3% cannot be explained solely by the amounts of cinnamaldehyde and eugenol contained.

Abstract

PCT No. PCT/EP95/01452 Sec. 371 Date Oct. 17, 1996 Sec. 102(e) Date Oct. 17, 1996 PCT Filed Apr. 18, 1995 PCT Pub. No. WO95/28098 PCT Pub. Date Oct. 26, 1995Smokable products made of tobacco and/or another smokable material, which comprise natural substances having an antioxidative effect and/or naturally identical synthetic products thereof. These natural substances are selected according to the invention from hydroxycinnamic acids and their esters and depsides, plant phenols which can be derived from hydroxycinnamic acids, polymers of hydroxycinnamic alcohols, further natural substances of plant origin which have antimutagenic and aromatizing properties and are combined with vitamins, their precursors and/or derivatives having an antioxidative effect, and further vitamins having an antioxidative effect which are complexed with eukaryotic cell cultures. Processes for the preparation of products of this type are furthermore described. Compared with conventional smokable products, the products have a distinctly decreased risk potential.

Description

Tabakerzeuσnisse oder Tabakerzeuσnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben Tobacco products or tobacco products similar goods with natural substances having an antioxidative effect and process for producing the same
Die vorliegende Erfindung betrifft Tabakerzeugnisse oder Tabak¬ erzeugnissen ähnliche Waren, die mit an sich bekannten antioxi¬ dativ wirkenden Naturstoffen und/oder naturidentischen Synthese¬ produkten derselben versehen und zum Rauchen bestimmt sind, sowie Verfahren zur Herstellung dieser Erzeugnisse.The present invention relates to tobacco products or tobacco-like products which are provided with known antioxidative natural substances and / or nature-identical synthesis products thereof and are intended for smoking, and to processes for producing these products.
Der menschliche Organismus ist einer naturgegebenen Grundbela¬ stung mit toxischen Substanzen ausgesetzt und wird daher mit einer Vielzahl von utagenen und kanzerogenen Stoffen konfron¬ tiert, die auf dem Wege des eigenen Stoffwechsels sogar zum Teil von ihm selbst gebildet werden.The human organism is exposed to a naturally occurring basic load of toxic substances and is therefore confronted with a large number of utagenic and carcinogenic substances, some of which are formed by itself through its own metabolism.
Der Mensch verfügt jedoch über verschiedene Abwehrmechanismen auf immunologischer, zellulärer und genetischer Ebene, um z.B. einer allergischen Reaktion, einer Zellschädigung oder einem Mutationsereignis im Bereich der Erbinformationen entgegenzuwir¬ ken. So existieren in den Zellen beispielsweise sogenannte "re- pair-Systeme" , mit deren Hilfe Erbgutveränderungen erkannt und eliminiert werden können. Lange Zeit wurde davon ausgegangen, daß zwischen der Einwirkung etwaiger Risikofaktoren wie z.B. diversen Produkten unvollstän¬ diger Verbrennung, verschiedenen Strahlungen und/oder elektroma¬ gnetischen Feldern, einigen Pflanzen- und Holzschutzmitteln, bestimmten Mineralfasern (z.B. Asbest) und bestimmten Stoffwech- selprodukten von Schimmelpilzen (z.B. Aflatoxin) auf den mensch¬ lichen Organismus und der Krebsentstehung ein direkter kausaler Zusammenhang besteht. Die Tatsache, daß die überwiegende Zahl der Menschen, die diesen Risikofaktoren ausgesetzt sind, nicht die zu erwartenden Symptome aufweist, hat jedoch zu einem Umden¬ ken in der Risikobewertung geführt. So kann die Höhe des Krebs¬ risikos nicht mehr allein vom potentiellen Schadstoff bzw. Expo¬ sitionsfaktor her definiert werden. Es muß vielmehr davon aus¬ gegangen werden, daß sie das Ergebnis einer multifaktoriellen Wechselbeziehung zwischen einer Vielzahl einwirkender Substan¬ zen/Mechanismen und belastetem Organismus ist. Ferner gilt als gesichert, daß mehrere Mutationsereignisse an bestimmten Stellen des Genoms erforderlich sind, damit aus einer normalen Körper¬ zelle eine entartete Zelle mit unkontrolliertem Wachstum ent- stehen kann.However, humans have various defense mechanisms at the immunological, cellular and genetic level in order to counteract, for example, an allergic reaction, cell damage or a mutation event in the area of genetic information. So-called “pairing systems” exist in the cells, for example, with the aid of which changes in the genetic material can be recognized and eliminated. For a long time it was assumed that between the effects of possible risk factors such as various products of incomplete combustion, various radiations and / or electromagnetic fields, some plant and wood preservatives, certain mineral fibers (eg asbestos) and certain metabolic products of mold (eg aflatoxin) there is a direct causal relationship to the human organism and the development of cancer. However, the fact that the vast majority of people who are exposed to these risk factors do not have the symptoms to be expected has led to a rethink in risk assessment. The level of cancer risk can no longer be defined solely from the potential pollutant or exposure factor. Rather, it must be assumed that it is the result of a multifactorial interrelation between a large number of acting substances / mechanisms and the contaminated organism. Furthermore, it is certain that several mutation events are required at certain locations in the genome so that a degenerate cell with uncontrolled growth can emerge from a normal body cell.
Besondere Bedeutung kommt dem körpereigenen Abwehrsystem zu, welches auch durch die Lebensweise individuell beeinflußt werden kann. So löst z.B. die Nahrungsaufnahme im Körper eine Reihe von chemischen Reaktionen aus, wobei sich mutagen und antimutagen wirkende Substanzen in enger Wechselbeziehung zueinander befin¬ den.The body's defense system is of particular importance, which can also be influenced individually by the way of life. For example, the food intake in the body causes a number of chemical reactions, whereby mutagenic and antimutagenic substances are in close interrelation.
Inzwischen wurden chemische Verbindungen identifiziert, die eine protektive Wirkung gegenüber mutagen wirkenden Stoffen aufweisen wie z.B. verschiedene Vitamine, Senföle und Beta-Carotin. Auch werden in Nahrungsmitteln enthaltene natürlich vorkommende pflanzliche Phenole wie z.B. Hydroxyzimtsäuren und deren Ver¬ bindungen aufgrund ihrer antioxidativen Eigenschaften als anti- mutagene und antikarzinogene Substanzen unterschiedlicher Inten¬ sität diskutiert (Karl Herrmann, "Hydroxyzimtsäure-Verbindungen als biologisch aktive Inhaltsstoffe von Lebensmitteln", Ernäh¬ rungs-Umschau 38, Heft 4, S. 148-154 (1991)). Diese Erkenntnisse stützen sich u.a. auf epidemiologische Befunde, die ein umge¬ kehrtes Verhältnis zwischen dem Konsum von Obst und Gemüse und verschiedenen Krebserkrankungen erkennen lassen.In the meantime, chemical compounds have been identified that have a protective effect against mutagenic substances such as various vitamins, mustard oils and beta-carotene. Naturally occurring vegetable phenols such as hydroxycinnamic acids and their compounds contained in foods are also discussed on the basis of their antioxidative properties as antimutagenic and anticarcinogenic substances of different intensities (Karl Herrmann, "Hydroxycinnamic acid compounds as biologically active ingredients of food ", Ernahr¬-Umschau 38, Issue 4, pp. 148-154 (1991)). These findings are based, among other things, on epidemiological findings that show an inverse relationship between the consumption of fruit and vegetables and different types of cancer.
Unter dem _n dieser Beschreibung verwendeten Begriff "Tabaker¬ zeugnisse" sind sowohl Cigaretten, Cigarillos und Tabakpatronen (sogenannte Steck-Cigaretten) mit oder ohne Filter als auch Feinschnitt und Pfeifentabak, die ganz oder anteilig aus Tabak und/oder einem anderen rauchbaren Material bestehen, sowie Ta- bakerzeυ^nissen ähnliche Rauchwaren wie beispielsweise "Kretek"- Cigaret: ;ι mit Zusatz von bis zu 50 Gew.% rauchbarer Gewürze, oder reine, tabakfreie Pflanzencigaretten zu verstehen.The term "tobacco products" used in this description includes both cigarettes, cigarillos and tobacco cartridges (so-called plug-in cigarettes) with or without a filter, as well as fine cut and pipe tobacco, which consist entirely or in part of tobacco and / or another smokable material, as well as tobacco candles similar tobacco products such as "Kretek" - cigaret:; ι with the addition of up to 50% by weight of smokable spices, or to understand pure, tobacco-free plant cigarettes.
Es ist bekannt, daß auch die Konsumenten von rauchbaren Tabak¬ erzeugnissen eine Vielzahl von organischen Verbindungen aufneh¬ men, von denen einige ein toxisches Potential für den mensch¬ lichen Organismus aufweisen, andere hingegen dieses reduzieren können. Bei der Diskussion über die gesundheitsgefährdenden Eigenschaften von Tabakerzeugnissen ist lange Zeit insbesondere die mutagene und krebsfördernde Wirkung einiger der durch Inha¬ lation in den menschlichen Körper gelangenden Tabakinhaltsstoffe in den Vordergrund gestellt worden. Wie bereits ausgeführt, besteht zwischen der Einwirkung von Schadstoffen und der Krebs¬ entstehung jedoch kein direkter kausaler Zusammenhang.It is known that consumers of smokable tobacco products also ingest a large number of organic compounds, some of which have a toxic potential for the human organism, while others can reduce this. In the discussion about the health-endangering properties of tobacco products, the mutagenic and cancer-promoting effects of some of the tobacco ingredients that enter the human body through inhalation have been put in the foreground for a long time. As already stated, there is no direct causal connection between the action of pollutants and the development of cancer.
Zahlreiche Versuchsreihen haben zu dem Ergebnis geführt, daß die in einem Tabakerzeugnis vorhandenen und entweder in der Gas- oder Partikelphase des Hauptstromrauches in den Organismus des Konsumenten gelangenden Stoffe bzw. Verbindungen nicht auf di¬ rektem Wege in der Lage sind, eine normale Zelle des menschli¬ chen Organismus in eine entartete Zelle umzuformen.Numerous series of tests have led to the result that the substances or compounds present in a tobacco product and entering the organism of the consumer either in the gas or particle phase of the main stream smoke are not able directly to a normal human cell ¬ Chen organism transform into a degenerate cell.
Demgemäß ist festzustellen, daß die in Laborversuchen nachweis¬ bare mutagene Wirkung von Inhaltsstoffen des Hauptstromrauches von Tabakerzeugnissen nicht unmittelbar mit einer kanzerogenen Wirkung gleichzusetzen ist, da die meisten in diesem Zusammen¬ hang zu nennenden Substanzen und Stoffgruppen ihr gefährdendes Potential erst durch den zelleigenen Metabolismus dieser Ver- bindungen entfalten. Diese Erkenntnisse über die mutagene Wir¬ kung wurden mit Hilfe des allgemein bekannten Arnes-Test gewonnen (D.M. Maron and B.N. Arnes, "Revised Methods for the Salmonella Mutagenicity Test", Handbook of Mutagenicity Test procedures, Elsevier Science Publishers BV, Her. B.J. Kilbey, M. Legator, W. Nichols und C. Ramel, 1984).Accordingly, it can be established that the mutagenic effect of ingredients of the mainstream smoke which can be demonstrated in laboratory tests of tobacco products cannot be directly equated with a carcinogenic effect, since most of the substances and groups of substances to be named in this context only develop their hazardous potential through the cell's own metabolism of these compounds. These findings about the mutagenic effect were obtained with the aid of the generally known Arnes test (DM Maron and BN Arnes, "Revised Methods for the Salmonella Mutagenicity Test", Handbook of Mutagenicity Test procedures, Elsevier Science Publishers BV, Her. BJ Kilbey , M. Legator, W. Nichols and C. Ramel, 1984).
Zur Reduzierung des Risikopotentials von rauchbaren Tabakerzeug¬ nissen sind bisher verschiedene Wege beschritten worden.Various approaches have been taken to reduce the risk potential of smokable tobacco products.
Zum einen wurden neue Filtersysteme geschaffen, durch die be¬ stimmte Schadstoffgruppen daran gehindert werden, in den Haupt- strσmrauch und damit in den Respirationstrakt des Konsumenten zu gelangen. So wird beispielsweise in der DE-PS 35 32 618 eine Dotierung der Filter von Filtercigaretten mit beispielsweise L- Ascorbinsäure offenbart, wodurch die Absenkung von Aldehyden des Hauptstromrauches von Cigaretten erheblich begünstigt werden soll. Aus der WO 89/01301 ist es bekannt, Filter von Filterciga¬ retten mit Ethanol und andere Alkohole enthaltenden Mikro- und Makrokapseln zu präparieren, um das Lungengewebe vor bestimmten toxischen Bestandteilen des Cigarettenrauches wie insbesondere Nitrosaminen durch vorherige "Blockierung" der betroffenen bzw. zugänglichen Areale mit bestimmten im Hauptstromrauch freige¬ setzten Alkoholen zu schützen.On the one hand, new filter systems were created, by means of which certain groups of pollutants are prevented from getting into the mainstream smoke and thus into the respiratory tract of the consumer. For example, in DE-PS 35 32 618 a doping of the filter of filter cigarettes with, for example, L-ascorbic acid is disclosed, whereby the lowering of aldehydes of the main stream smoke from cigarettes is said to be significantly promoted. From WO 89/01301 it is known to prepare filters of filter cigarettes with microcapsules and macrocapsules containing ethanol and other alcohols in order to protect the lung tissue from certain toxic constituents of cigarette smoke, such as in particular nitrosamines, by "blocking" the affected or accessible one beforehand To protect areas with certain alcohols released in the mainstream smoke.
Weiterhin wurde versucht, den Tabak von Filtercigaretten mit bestimmten Stoffen zu imprägnieren, um bereits den Gehalt be¬ stimmter Schadstoffe im Hauptstromrauch zu reduzieren. So ist es aus der OE-PS 340 297 und der OE-PS 240 298 bekannt, Tabak mit Ascorbinsäure bzw. mit Salzen davon zu beaufschlagen, um den Stickstoffdioxid-Gehalt des Cigarettenrauches zu reduzieren. Ferner wurde gemäß EP-PS 0 116 085 ein Verfahren zur Imprä- gnierung von Filtercigaretten mit Interferon oder biologisch aktiven Fragmenten davon offenbart. Derartig behandelte Cigaret¬ ten sollen die körpereigene Produktion von Interferon aktivieren und somit das Immunsystem unterstützen.Attempts have also been made to impregnate the tobacco of filter cigarettes with certain substances in order to reduce the content of certain pollutants in the mainstream smoke. It is known from OE-PS 340 297 and OE-PS 240 298 to act on tobacco with ascorbic acid or with salts thereof in order to reduce the nitrogen dioxide content of the cigarette smoke. Furthermore, according to EP-PS 0 116 085, a method for impregnating gnierung of filter cigarettes with interferon or biologically active fragments thereof disclosed. Cigarettes treated in this way are said to activate the body's production of interferon and thus to support the immune system.
Auf diese Weise hergestellte Produkte tragen zwar dazu bei, po¬ tentielle Risiken des Rauchens zu vermindern, sie beinhalten aber auch systemimmanente Nachteile. Zum einen werden lediglich bestimmte toxische Bestandteile überwiegend der Gasphase des Cigarettenrauches im nichtverbrannten Abschnitt des Cigaretten- stranges (N02) bzw. im Filter (Aldehyde) mittels Chemisorption zurückgehalten, während der Gehalt des Hauptstromrauches an anderen Schadstoffen jedoch nicht beeinflußt wird. Zum anderen soll das Erzeugen einer "Schutzschicht" innerhalb des Organismus gemäß WO 89/01301 wiederum nur gegenüber bestimmten Schadstoffen wie beispielsweise den Nitrosaminen gelingen. Der Einsatz von Interferon gemäß EP-PS 0 116 085 ist hingegen mit erheblichen Kosten verbunden.Products manufactured in this way help to reduce potential risks of smoking, but they also have disadvantages inherent in the system. On the one hand, only certain toxic components are predominantly retained in the gas phase of the cigarette smoke in the unburned section of the cigarette rod (N0 2 ) or in the filter (aldehydes) by means of chemisorption, while the content of the main stream smoke in other pollutants is not influenced. On the other hand, the creation of a "protective layer" within the organism according to WO 89/01301 should in turn only succeed against certain pollutants such as, for example, the nitrosamines. The use of interferon according to EP-PS 0 116 085, however, is associated with considerable costs.
Die Aufgabe der vorliegenden Erfindung besteht daher in der Schaffung einer weiteren Rauchware, die Zusätze enthält, durch die die potentiellen Risiken des Rauchens weiter vermindert werden, sowie in der Bereitstellung eines Verfahrens zur Her¬ stellung derartiger Rauchwaren.The object of the present invention is therefore to create a further smoking article which contains additives which further reduce the potential risks of smoking, and to provide a method for producing such smoking articles.
Zur Lösung dieser Aufgabe wird ein rauchbares Erzeugnis aus Tabak und/oder einem anderen rauchbaren Material vorgeschlagen, das antioxidativ wirkende Naturstoffe und/ oder naturidentische Syntheseprodukte derselben umfaßt, welche ausgewählt sind aus:To achieve this object, a smokable product made from tobacco and / or another smokable material is proposed, which comprises antioxidative natural substances and / or nature-identical synthesis products thereof, which are selected from:
(a) Hydroxyzimtsäuren, deren Estern und Depsiden;(a) hydroxycinnamic acids, their esters and depsides;
(b) von Hydroxyzimtsäuren ableitbaren pflanzlichen Phenolen;(b) vegetable phenols derived from hydroxycinnamic acids;
(c) Polymeren der Hydroxyzimtalkohole; (d) Kombinationen weiterer Naturstoffe pflanzlichen Ursprungs, die antimutagene und aromatisierende Eigenschaften aufwei¬ sen, mit antioxidativ wirkenden Vitaminen, ihren Vorstufen und/oder Derivaten;(c) polymers of the hydroxycinnamic alcohols; (d) combinations of other natural substances of plant origin which have antimutagenic and aromatizing properties, with antioxidant vitamins, their precursors and / or derivatives;
(e) Komplexen antioxidativ wirkender Vitamine mit eukaryonti- schen Zellkulturen.(e) complexes of antioxidant vitamins with eukaryotic cell cultures.
Es wurde überraschenderweise gefunden, daß das erfindungsgemäße rauchbare Erzeugnis ein gegenüber herkömmlichen Produkten deut¬ lich vermindertes Risikopotential aufweist.It has surprisingly been found that the smokable product according to the invention has a significantly lower risk potential than conventional products.
Bei dem erfindungsgemäßen Tabakerzeugnis sind die Hydroxyzimt¬ säuren p-Cumarsäure, Kaffeesäure und Ferulasäure bevorzugt. Die bevorzugten Ester der Hydroxyzimtsäuren sind deren Methyl- und Ethylester, während die bevorzugten Depside der Hydroxyzimtsäu¬ ren aus deren Verbindungen mit Fruchtsäuren oder Chinasäure bestehen, von denen Chlorogensäuren besonders bevorzugt sind.In the tobacco product according to the invention, the hydroxycinnamic acids p-cumaric acid, caffeic acid and ferulic acid are preferred. The preferred esters of hydroxycinnamic acids are their methyl and ethyl esters, while the preferred deposits of hydroxycinnamic acids consist of their compounds with fruit acids or quinic acid, of which chlorogenic acids are particularly preferred.
Erfindungsgemäß sind die von Hydroxyzimtsäuren ableitbaren pflanzlichen Phenole Umbelliferon, Aesculetin, Scopoletin, Cur- cumin, Ellagsäure und Dihydrokaffeesäure bevorzugt, während die Polymere der Hydroxyzimtalkohole bevorzugt aus p-Coumarylalko- hol, Coniferylalkohol und Sinapylalkohol abgeleitet sind.According to the invention, the plant phenols derivable from hydroxycinnamic acids umbelliferone, aesculetin, scopoletin, curcumin, ellagic acid and dihydrocaffeic acid are preferred, while the polymers of the hydroxycinnamic alcohols are preferably derived from p-coumaryl alcohol, coniferyl alcohol and sinapyl alcohol.
Die weiteren Naturstoffe pflanzlichen Ursprungs mit sowohl anti- mutagenen als auch aromatisierenden Eigenschaften sind bevorzugt Vanillin, Ethylvanillin, Zimtaldehyd, Anisaldehyd, Cumarin, 6- Methylcumarin, Eugenol, Jasminaldehyd, Anethol, p-Anisylaceton, Limonen, Zimt und Zimtextrakt. Die mit diesen weiteren Natur¬ stoffen pflanzlichen Ursprungs erfindungsgemäß kombinierten antioxidativ wirkenden Vitamine sind vorzugsweise Ascorbinsäure, ß-Carotin, Retinol und -Tocopherol sowie deren Derivate, gege¬ benenfalls in Kombination miteinander und/oder anderen Vitami- nen. Besonders bevorzugt sind stabile Derivate der Ascorbinsäure wie Ascorbinsäure-Palmitat oder Ascorbigen (Ascorbinsäure gebun- O 95/28098 PCΪ7EP95/01452The other natural substances of plant origin with both anti-mutagenic and flavoring properties are preferably vanillin, ethylvanillin, cinnamaldehyde, anisaldehyde, coumarin, 6-methylcoumarin, eugenol, jasmine aldehyde, anethole, p-anisylacetone, limonene, cinnamon and cinnamon extract. The antioxidative vitamins combined according to the invention with these other natural substances of plant origin are preferably ascorbic acid, β-carotene, retinol and tocopherol and their derivatives, optionally in combination with one another and / or other vitamins. Stable derivatives of ascorbic acid such as ascorbic acid palmitate or ascorbigen (ascorbic acid bound O 95/28098 PCΪ7EP95 / 01452
- 7 -- 7 -
den an Indol). Als weitere Vitamine, die antioxidativ wirken und mit eukaryontisehen Zellkulturen komplexiert sind, werden ß- Carotin, Retinol und α-Tocopherol sowie deren Derivate bevor¬ zugt.to indole). As further vitamins, which have an antioxidative effect and are complexed with eukaryotic cell cultures, β-carotene, retinol and α-tocopherol and their derivatives are preferred.
Die jeweiligen Molekulargewichte sowie Schmelz- und Siedepunkte der erfindungsgemäßen Naturstoffe der Gruppen (a) bis (d) sind in Tabelle 1 aufgeführt.The respective molecular weights and melting and boiling points of the natural substances according to the invention of groups (a) to (d) are listed in Table 1.
Die erfindungsgemäß bevorzugten Hydroxyzimtalkohole sind p-Cou- marylalkohol, Coniferylalkohol und Sinapylalkohol und bilden das in verholzenden Pflanzen vorkommende Lignin. Hierbei werden die verschiedenen Hydroxyzimtalkohole in variierendem mengenmäßigen Anteil in verschiedenen Verknüpfungsformen in Makromoleküle eingebunden. Die Festigkeit des Holzes wird wesentlich durch die Einlagerung von Lignin in Cellulose bewirkt.The preferred hydroxycinnamic alcohols according to the invention are p-comaryl alcohol, coniferyl alcohol and sinapyl alcohol and form the lignin which occurs in woody plants. The various hydroxycinnamic alcohols are incorporated into macromolecules in varying amounts in various forms of linkage. The strength of the wood is essentially caused by the incorporation of lignin in cellulose.
Es hat sich gezeigt, daß in zerfasertem Holz die antioxidativen phenolischen Eigenschaften des Lignins wirksam werden können. Vornehmlich frisch präparierte Holzfasern sind in der Lage, das mutagene Potential von darüber geleitetem Rauch zu vermindern.It has been shown that the antioxidative phenolic properties of lignin can be effective in shredded wood. Freshly prepared wood fibers in particular are able to reduce the mutagenic potential of smoke passed over them.
Nach einer bevorzugten Ausführungsform sind die antioxidativ wirkenden Naturstoffe und/oder naturidentischen Syntheseprodukte derselben in dem Tabakerzeugnis einzeln oder in Kombination enthalten, wobei deren relative, auf das Gesamtgewicht bezogene Einsatzmengen in Abhängigkeit des oder der vorgesehenen Zielkom¬ ponenten eines rauchbaren Tabakerzeugnisses variieren können. Grundsätzlich können die Naturstoffe sowohl in den Rauchtabak inklusive der gängigen Zuschlagsstoffe als auch in einzelne dem Hauptstromrauch zugängliche Komponenten der Tabakerzeugnisse wie Filter, Hüllpapiere, Trägerstoffe, Na.htleim etc. in an sich be¬ kannter Weise eingearbeitet bzw. aviviert werden, was sowohl beim Hersteller des Tabakerzeugnisses als auch anteilig bei dessen Zulieferer geschehen kann. Wenn die reinen Naturstoffe dem Tabak zugesetzt werden, liegt ihre bevorzugte relative Einsatzmenge im Bereich von 0,1 Promil¬ le bis 25 Gew.-%, wobei ein Gehalt zwischen 1 und 5 Gew.-% be¬ sonders bevorzugt ist. Werden die reinen Naturstoffe in den Filter oder in das Cigarettenpapier bzw. in den Leim der Ciga- rettennaht eingearbeitet, betragen die bevorzugten Mengen 0,1 bis 50 Gew.-%, wobei Mengen von 1 bis 20 Gew.-% besonders bevor¬ zugt sind. Der verwendete Filter kann ein Kammerfilter, ein Celluloseacetatfilter oder ein Cellulose-Wirrfaservlies-Filter oder ein Mehrfachfilter, vorzugsweise ein Doppelfilter (jeweils mit oder ohne Filterventilierung) sein, wobei der Doppelfilter einen höheren strangseitigen Zugwiderstand und einen niedrigeren mundseitigen Zugwiderstand sowie einen Gesamtfilter-Wirkungsgrad von 80 - 99% aufweist. Ebenso können auch Filter aus anderen an sich bekannten Filtermaterialien in Kombination mit den antioxi¬ dativ wirkenden Naturstoffen eingesetzt werden.According to a preferred embodiment, the antioxidative natural substances and / or nature-identical synthesis products thereof are contained in the tobacco product individually or in combination, their relative amounts based on the total weight being able to vary depending on the intended component or components of a smokable tobacco product. In principle, the natural substances can be incorporated or upgraded in a known manner both in the smoking tobacco including the conventional additives and in individual components of the tobacco products that are accessible to the mainstream smoke, such as filters, wrapping papers, carrier substances, Na glue, etc. Manufacturer of the tobacco product can also happen proportionately with its suppliers. If the pure natural substances are added to tobacco, their preferred relative use amount is in the range of 0.1 per thousand to 25% by weight, a content between 1 and 5% by weight being particularly preferred. If the pure natural substances are incorporated in the filter or in the cigarette paper or in the glue of the cigarette seam, the preferred amounts are 0.1 to 50% by weight, with amounts of 1 to 20% by weight being particularly preferred are. The filter used can be a chamber filter, a cellulose acetate filter or a cellulose random-fiber fleece filter or a multiple filter, preferably a double filter (in each case with or without filter ventilation), the double filter having a higher line-side draw resistance and a lower mouth-side draw resistance and an overall filter efficiency of 80 - 99%. Filters made from other filter materials known per se can also be used in combination with the antioxidative natural substances.
Sind die erfindungsgemäßen Naturstoffe von vornherein in nicht- tabakhaltigen, überwiegend pflanzlichen rauchbaren Materialien enthalten, die dem Tabak zugesetzt werden, oder besteht alterna¬ tiv die rauchbare Mischung ausschließlich aus gegebenenfalls verschiedenen, aufeinander abgestimmten, nichttabakhaltigen, pflanzlichen Materialien mit oder ohne pflanzeneigenen, erfin¬ dungsgemäßen Naturstoffen, so gelten ebenfalls die bevorzugten, auf die reinen Naturstoffe zu beziehenden Einsatzmengen von 0,1 Promille bis 25 Gew.-%, ebenso die besonders bevorzugten Ein¬ satzmengen von 1,0 bis 5 Gew.-%, wobei in allen Fällen die vor¬ gesehene Einsatzmenge durch Zugabe der reinen Naturstoffe bzw. der reinen erfindungsgemäßen Substanzen zur rauchbaren Mischung ergänzt werden kann. Eine weitere bevorzugte Einsatz- oder An¬ bieteform des die antioxidativ wirkenden Naturstoffe, insbeson¬ dere Vitamine wie α-Tocopherol oder ß-Carotin enthaltenden, natürlichen Materials, sind dabei kultivierte Eukaryontenzellen, deren Trockenmasse zwischen 0,5 und 15 Gew.-% der antioxidativ wirkenden Vitamine in festgebundener bzw. festangelagerter Form enthalten kann, wie beispielsweise speziell kultivierte Tabak¬ oder Hefezellen.Are the natural substances according to the invention contained from the start in non-tobacco-containing, predominantly vegetable smokable materials that are added to the tobacco, or alternatively the smokable mixture consists exclusively of optionally different, coordinated, non-tobacco-containing, vegetable materials with or without the plant's own inventions Natural substances according to the invention also apply to the preferred amounts of 0.1 per mille to 25% by weight, based on the pure natural substances, and also the particularly preferred amounts of use of 1.0 to 5% by weight, in all cases the intended use can be supplemented by adding the pure natural substances or the pure substances according to the invention to the smokable mixture. A further preferred use or offer form of the natural material containing the antioxidative natural substances, in particular vitamins such as α-tocopherol or β-carotene, are cultured eukaryotic cells, the dry matter of which is between 0.5 and 15% by weight of the antioxidant vitamins in fixed or fixed form May contain, such as specially cultivated tobacco or yeast cells.
So ist es nach an sich bekannten Verfahren (z.B. W. Röper et al., J. Plant Physiol. 118. 463-470 (1985) und DE-PS 2 144 460) möglich, Tabakzellen in flüssigen Kultursubstraten zur Herstel¬ lung eines Tabakersatzmaterials zu kultivieren.Thus, according to methods known per se (for example W. Röper et al., J. Plant Physiol. 118, 463-470 (1985) and DE-PS 2 144 460) it is possible to use tobacco cells in liquid culture substrates for producing a tobacco substitute material to cultivate.
Im Rahmen der vorliegenden Erfindung hat sich überraschenderwei- es gezeigt, daß sich die erfindungsgemäßen antioxidativen Na¬ turstoffe fest an die kultivierten Eukaryontenzellen anlagern, wenn sie der Kulturbrühe in geeigneten Konzentrationen zugegeben werden. Beispielsweise betragen die Konzentrationen im Falle von α-Tocopherol (in Form von α-Tocopherolacetat) 0,01 bis 10, vor- zugs.weise 0,05 bis 2 Vo.-.-%, und im Falle von ß-Carotin 0,01 bis 0,5, vorzugsweise 0,05 bis 0,2 Vol.-%o. Anschließend können die somit entstandenen erfindungsgemäßen Komplexe nach Filtration aus der Kulturbrühe und Trocknung der rauchbaren Mischung bei¬ gefügt werden. In the context of the present invention, it has surprisingly been found that the antioxidative natural substances according to the invention firmly attach themselves to the cultured eukaryotic cells when they are added to the culture broth in suitable concentrations. For example, the concentrations in the case of α-tocopherol (in the form of α-tocopherol acetate) are 0.01 to 10, preferably 0.05 to 2% by volume, and in the case of β-carotene 0, 01 to 0.5, preferably 0.05 to 0.2 vol .-% o. The complexes according to the invention thus formed can then be added after filtration from the culture broth and drying of the smokable mixture.
Tabelle 1 Erfindungsgemäße phenolische PflanzeninhaltsstoffeTable 1 Phenolic phytonutrients according to the invention
Inhaltsstoff MG Kp (°C) Fp (°C)Ingredient MG Kp (° C) Fp (° C)
p-Cumarsäure 164.2 sublimiert 214-217 (Zers.) p-Cumarsäure-Methylester 178.2 139 p-Cumarsäure-Ethylester 192.2 87p-Cumaric acid 164.2 sublimates 214-217 (decomp.) p-cumaric acid methyl ester 178.2 139 p-cumaric acid ethyl ester 192.2 87
Kaffeesäure 180.2 215-220 (Zers.)Caffeic acid 180.2 215-220 (dec.)
Kaffeesäure-Methylester 194.2 157-158Caffeic acid methyl ester 194.2 157-158
Kaffeesäure-Ethylester 208.2 149-150Caffeic acid ethyl ester 208.2 149-150
Ferulasäure 194.2 170-172Ferulic acid 194.2 170-172
Ferulasäure-Methylester 208.2 163 bei 1 mm Hg 65Ferulic acid methyl ester 208.2 163 at 1 mm Hg 65
Ferulasäure-Ethylester 222.2 185 bei 3 mm Hg 58Ferulic acid ethyl ester 222.2 185 at 3 mm Hg 58
Chlorogensäure 354.3 208-210 (Zers.)Chlorogenic acid 354.3 208-210 (dec.)
Umbelliferon 162.2 sublimiert 230-233Umbelliferon 162.2 sublimes 230-233
Aesculetin 178.2 sublimiert 272-275 (Zers.)Aesculetin 178.2 sublimates 272-275 (dec.)
Scopoletin 192.2 204-206Scopoletin 192.2 204-206
Curcumin 368.4 175-180Curcumin 368.4 175-180
Ellagsäure 302.2 >350Ellagic acid 302.2> 350
Dihydrokaifeesäure 182.2 133-137Dihydrokaifeic acid 182.2 133-137
Vanillin 152.2 170 bei 15 mm Hg 81-83Vanillin 152.2 170 at 15 mm Hg 81-83
EtbylvaniHin 166.2 74-77EtbylvaniHin 166.2 74-77
Zimtaldehyd 132.2 253 -7.5Cinnamaldehyde 132.2 253 -7.5
Anisaldehyd 136.2 248 25Anisaldehyde 136.2 248 25
Cumarin 146-2 297-299 68-71Coumarin 146-2 297-299 68-71
6-Methylcumarin 160.2 303 75-766-methylcoumarin 160.2 303 75-76
Eugenol 164.2 253-255 -9Eugenol 164.2 253-255 -9
Jasminaldehyd 2023 287-290 -Jasmine aldehyde 2023 287-290 -
Aπethol 148.2 232-237 20-23 p-Anisylaceton 178.2 152-153 bei 15 mm Hg 8Ethanol 148.2 232-237 20-23 p-Anisylacetone 178.2 152-153 at 15 mm Hg 8
Limonen 136,2 176 -97 O 95/28098 PCΪ7EP95/01452Lime 136.2 176 -97 O 95/28098 PCΪ7EP95 / 01452
- 11 -- 11 -
Beispielsweise können die erfindungsgemäßen Substanzen beim Fertigen einer rauchbaren Mischung auf an sich bekannte Weise dem Blattschnitt und/oder dem Rippenschnitt zugesetzt werden, gegebenenfalls unter Einsatz bekannter Haft- und Bindemittel. Alternativ können die Substanzen auf bekannte Weise in Folien¬ oder Bandtabak eingearbeitet werden, was sich insbesondere bei der Verwendung fester, gemahlener Naturstoffe anbietet. Hierbei kann auch eine neuartige, nichttabakhaltige Pflanzenfolie einge¬ setzt werden, die zumindest anteilig die erfindungsgemäßen Na- turstoffe in Form pflanzeneigener Inhaltsstoffe von Teilen des pflanzlichen Folienmaterials enthält. Vorzugsweise ist das rauchbare Basis-Material eine Mischung aus Lamina-Tabaken oder eine Mischung aus Lamina-Tabak und Folientabak oder eine tabak¬ freie Mischung aus Pflanzenmaterial, welches sich von Huflat- tich, Pfefferminze, Brennessel, Breitwegerich, Krauseminze, Lavendel, Thymian, Süß- oder Sauerkirschblättern, Knöterichblät¬ tern, Rosenblättern, Pimentblättern oder Zimtrinde ableitet. Alternativ ist es bevorzugt, daß das rauchbare Material eine Kombination aus Tabakmischung und tabakfreier Mischung ist.For example, when producing a smokable mixture, the substances according to the invention can be added to the leaf cut and / or the rib cut in a manner known per se, if appropriate using known adhesives and binders. Alternatively, the substances can be incorporated into film or tape tobacco in a known manner, which is particularly useful when using solid, ground natural substances. A novel, non-tobacco-containing plant film can also be used here, which at least partially contains the natural substances according to the invention in the form of plant-specific ingredients of parts of the plant film material. The smokable base material is preferably a mixture of lamina tobacco or a mixture of lamina tobacco and foil tobacco or a tobacco-free mixture of plant material which is made from coltsfoot, peppermint, nettle, white plantain, spearmint, lavender, thyme, Sweet or sour cherry leaves, knotweed leaves, rose leaves, allspice leaves or cinnamon bark are derived. Alternatively, it is preferred that the smokable material be a combination of tobacco blend and tobacco-free blend.
Ferner können die erfindungsgemäßen Substanzen in flüssiger Form den Casing- und/oder Flavorstoffen zugesetzt werden, wobei sie diese sogar ersetzen können.Furthermore, the substances according to the invention can be added to the casing and / or flavoring substances in liquid form, and they can even replace them.
Die üblichen Filtersysteme bestehen im wesentlichen entweder aus einem Filterfaser-Tow aus Celluloseacetatfasern oder aus mitein¬ ander verfilzten Cellulosefasern, die ein Cellulose-Wirrfa- servlies ergeben. Das Filterfasertow wird normalerweise während der Fertigung des Cigarettenfilters mit einem der zulässigen Härter besprüht, um die Fasern zu vernetzen und damit den Filter zu härten. Diese Härter bestehen zumeist aus Triacetin oder .Triethylenglykoldiacetat (TEGDA) und können erfindungsgemäß zum Teil oder vollständig durch die erfindungsgemäßen Naturstoffe in flüssiger Form ersetzt werden, sofern sie sich im Härter lösen oder aber selbst als Härter wirken wie beispielsweise Eugenol. In selber erfindungsgemäß als Härter einsetzbaren flüssigen Naturstoffen wie Eugenol, oder in üblichen Härtern wie TEGDA oder Triacetin können erfindungsgemäß wiederum andere Naturstof¬ fe wie Zimtaldehyd, Jasminaldehyd, Ethylvanillin und 6-Methylcu- marin, aber auch α-Tocopherol , Tocopherolacetat, Tocopherolsuc- cinat, Retinol und Retinolpalmitat gelöst werden, so daß sich bi- oder ternäre oder multiple Lösungsgemische ergeben, die vor¬ teilhafterweise sowohl als Härter für Celluloseacetatfasern als auch als Casingstoffe für rauchbare Mischungen eingesetzt werden können.The usual filter systems essentially consist either of a filter fiber tow made of cellulose acetate fibers or of cellulose fibers which are matted together, which result in a cellulose random fiber fleece. The filter fiber tow is normally sprayed with one of the permitted hardeners during the manufacture of the cigarette filter in order to crosslink the fibers and thus harden the filter. These hardeners mostly consist of triacetin or. Triethylene glycol diacetate (TEGDA) and can, according to the invention, be partly or completely replaced by the natural substances according to the invention in liquid form, provided that they dissolve in the hardener or act as hardeners themselves, for example eugenol. In liquid usable according to the invention as a hardener Natural substances such as eugenol, or in conventional hardeners such as TEGDA or triacetin, can, according to the invention, in turn be used to dissolve other natural substances such as cinnamaldehyde, jasmine aldehyde, ethylvanillin and 6-methylcumin, but also α-tocopherol, tocopherol acetate, tocopherol succinate, retinol and retinol palmitate, so that bi- or ternary or multiple solution mixtures result which can advantageously be used both as hardeners for cellulose acetate fibers and as casing substances for smokable mixtures.
Ferner sind Suspensionen fester Naturstoffe im Härter einsetz¬ bar, aber auch Einstreuungen gemahlener Naturstoffe in Filterfa- ser-Tow aus Celluloseacetatfasern.Suspensions of solid natural substances can also be used in the hardener, but also scattering of ground natural substances in filter fiber tow made of cellulose acetate fibers.
Die unterschiedlichen Löslichkeiten und Mischbarkeiten einiger erfindungsgemäß bevorzugter Aromastoffe und Vitamine in bzw. mit den üblichen Härtersubstanzen Triacetin und TEGDA sowie dem erfindungsgemäß selbst als Härtersubstanz verwendbaren natürli¬ chen Aromastoff Eugenol sind in Tabelle 2 dargestellt. Aus den Daten der Tabelle 2 sind insbesondere die ausgezeichneten lö¬ sungsvermittelnden Eigenschaften des erfindungsgemäß als Härter bzw. Härterkomponente einsetzbaren Eugenols zu ersehen. Die Substanz Eugenol kann jedoch auch in Form einer Mischung mit anderen in den Tabellen 2 und 3 als Härter bzw. Lösungsmittel aufgeführten Stoffen Verwendung finden, wobei die konkreten Mischungen und ihre jeweiligen Anteile unter Berücksichtigung ihrer Eigenschaften und ihrer Marktpreise sowie in Abhängigkeit des bzw. der zu behandelnden Komponenten des erfindungsgemäßen Erzeugnisses leicht ausgewählt werden können. Besonders bevor- zugt ist eine Mischung aus 80 Teilen Triacetin, 15 Teilen Euge¬ nol und 5 Teilen α-Tocopherolacetat. Die in diesem Verhältnis gemischten Substanzen ergeben eine klare Lösung, aus welcher nach Aufgabe auf Celluloseacetatfasern bevorzugt Triacetin und Eugenol in das Innere der Fasern diffundieren, wodurch das - Tocopherolacetat auf der Oberfläche der Filterfasern angerei¬ chert wird, und somit besonders leicht vom hier als Emittor wirkenden "Filter" in den Hauptstromrauch transferiert werden kann.The different solubilities and miscibilities of some flavoring substances and vitamins preferred according to the invention in or with the customary hardener substances triacetin and TEGDA and the natural flavoring substance eugenol which can itself be used according to the invention as a hardening substance are shown in Table 2. The data in Table 2 show in particular the excellent solution-imparting properties of the eugenol which can be used according to the invention as a hardener or hardener component. However, the substance eugenol can also be used in the form of a mixture with other substances listed in Tables 2 and 3 as hardeners or solvents, the specific mixtures and their respective proportions taking into account their properties and their market prices and depending on the or components of the product according to the invention to be treated can easily be selected. A mixture of 80 parts of triacetin, 15 parts of eugenol and 5 parts of α-tocopherol acetate is particularly preferred. The substances mixed in this ratio result in a clear solution, from which triacetin and eugenol preferably diffuse into the interior of the fibers after application to cellulose acetate fibers, as a result of which the tocopherol acetate is enriched on the surface of the filter fibers, and thus particularly easily from here as an emitter acting "filter" can be transferred into the main stream smoke.
Wenn der im Verfahren zur Herstellung eines Tabakerzeugnisses zu verwendende Filter nicht aus Celluloseacetatfasern besteht, wird er und/oder die anderen Komponenten des späteren Erzeugnisses wie das rauchbare tabakhaltige oder tabakfreie pflanzliche Mate¬ rial, das Cigarettenpapier und der zu verwendende Nahtleim er¬ findungsgemäß mit einer Lösung aus den erfindungsgemäßen Aroma¬ stoffen und Vitaminen (bzw. Provitaminen) behandelt, wobei als Lösungsmittel wiederum einzelne Vertreter dieser Stoffgruppen verwendbar sind. Die jeweiligen Löslichkeiten und Mischbarkeiten der gesamten Stoffe in bzw. mit einigen der erfindungsgemäß auch als Lösungsmittel .einsetzbaren Naturstoffe sind in Tabelle 3 dargestellt.If the filter to be used in the process for producing a tobacco product does not consist of cellulose acetate fibers, it and / or the other components of the later product such as the smokable tobacco-containing or tobacco-free vegetable material, the cigarette paper and the suture to be used according to the invention are provided with a Solution from the aromatic substances and vitamins (or provitamins) treated according to the invention, individual representatives of these groups of substances being usable as solvents. The respective solubilities and miscibilities of the entire substances in or with some of the natural substances which can also be used as solvents according to the invention are shown in Table 3.
Tabelle 2Table 2
Löslichkeit von antioxidativ wirksamen Aromastoffen und den Vitaminen A und E in FilterhärternSolubility of antioxidant aromas and vitamins A and E in filter hardeners
Aromastoffe VitamineFlavoring vitamins
Härter Zimt¬ Jasmin- Ethyl- 6-Methyl- A A E E E aldehyd aldehyd vanillin cumarin Palmitat Acetat SucciHardener cinnamon jasmine ethyl 6 methyl A A E E aldehyde aldehyde vanillin coumarin palmitate acetate succi
Triacetin M M > 10 > 10 > 10 < 1 > 10 < 1 < 1 TEGDA M M > 10 > 10 > 10 < 1 M < 1 < 1 Eugenol M M > 10 > 10 > 10 < 1 M M 10Triacetin M M> 10> 10> 10 <1> 10 <1 <1 TEGDA M M> 10> 10> 10 <1 M <1 <1 Eugenol M M> 10> 10> 10 <1 M M 10
TEGDA= TriethylenglykoldiacetatTEGDA = triethylene glycol diacetate
M = mischbar zu gleichen TeilenM = miscible in equal parts
>10 = Löslichkeit größer als 10 Gew.-%> 10 = solubility greater than 10% by weight
<1 = Löslichkeit kleiner als 1 Gew.-% Tabelle 3<1 = solubility less than 1% by weight Table 3
Lösungen aus antioxidativ wirksamen Aromastoffen und den Vitaminen A und E sowie ß-Carotin zur Behandlung von Filtern, Tabak, Cigarettenpapier und NahtleimSolutions made from antioxidant flavors and vitamins A and E and ß-carotene for the treatment of filters, tobacco, cigarette paper and seam glue
Aromastoffe Provitamin VitamineFlavoring provitamin vitamins
als Eugenol Jasmin¬ Zimt¬ Ethyl- 6-Methyl- ß-Carotin A E E E Lösungsmittel aldehyd aldehyd vanillin cumarin Acetat Succinatas eugenol jasmine cinnamon ethyl 6-methyl ß-carotene A E E E solvent aldehyde aldehyde vanillin coumarin acetate succinate
Eugenol X M M >10 >10 <1 >10 M M >10Eugenol X M M> 10> 10 <1> 10 M M> 10
Jasminaldehyd M X M >10 >10 <1 >10 M M >10Jasmine aldehyde M X M> 10> 10 <1> 10 M M> 10
Zimtaldehyd M M X >10 >10 >1 >10 M M >10Cinnamaldehyde M M X> 10> 10> 1> 10 M M> 10
Vitamin-E-Acetat M M M <1 <1 <1 <1 M x n.b.Vitamin E acetate M M M <1 <1 <1 <1 M x n.b.
M = mischbar zu gleichen TeilenM = miscible in equal parts
>10 = Löslichkeit größer als 10 Gew.-%> 10 = solubility greater than 10% by weight
>1 = Löslichkeit größer als 1 Gew.-%> 1 = solubility greater than 1% by weight
<1 = Löslichkeit kleiner als 1 Gew.-% <1 = solubility less than 1% by weight
Bei Verwendung des Cellulose- irrfaservlieses können die erfin¬ dungsgemäßen Substanzen bereits seitens des Filtermaterialher¬ stellers in das Vlies eingearbeitet werden. Hierbei können letztlich die üblicherweise gebleichten Cellulosefasern von beispielsweise einjährigen Pflanzen des bekannten Wirrfaservlie¬ ses anteilig oder überwiegend, vorzugsweise bis zu 85 % durch geeignete, ausreichend antioxidativ wirkendes Lignin enthaltende ungebleichte Holzschliff-"Fasern" ausgetauscht werden. Zudem können die erfindungsgemäßen festen Substanzen beispielsweise in gekörnter Form mit einem Korndurchmesser von etwa 0,8 mm seitens des Filterstabherstellers in die Kammern von Kammerfiltern ein¬ gebracht werden, ebenso erfindungsgemäße flüssige Substanzen, aufgenommen von beispielsweise Holzmehl- oder Ligningranulat, wobei besonders geeignete bzw. viel antioxidativ wirkendes Lig- nin enthaltende Holzteilchen in Faser-Staub- oder Granulatform dabei auch solitär als Kammereinlagerungsmaterialien oder als selbsttragende, poröse bzw. rauchdurchlässige Preßlinge im ge¬ wünschten Filterformat eingesetzt werden können. Ferner kann auch die beim Abrauchen mit dem Hauptstromrauch in Kontakt tre- tende Innenseite des Filterumhüllungspapiers mit den erfindungs¬ gemäßen Naturstoffen beschichtet sein.When using the cellulose fiber fleece, the substances according to the invention can already be incorporated into the fleece by the filter material manufacturer. Ultimately, the usually bleached cellulose fibers of, for example, annual plants of the known random fiber fleece can be exchanged partially or predominantly, preferably up to 85%, with suitable unbleached wood pulp "fibers" containing lignin with sufficient antioxidant activity. In addition, the solid substances according to the invention can be introduced into the chambers of chamber filters, for example in granular form with a grain diameter of about 0.8 mm, by the filter rod manufacturer, as can liquid substances according to the invention, taken up, for example, from wood flour or lignin granules, with particularly suitable or wood particles in fiber-dust or granule form containing a lot of antioxidative action can also be used as solitary as chamber embedding materials or as self-supporting, porous or smoke-permeable compacts in the desired filter format. Furthermore, the inside of the filter wrapping paper that comes into contact with the mainstream smoke when it is smoking can also be coated with the natural substances according to the invention.
Das Cigarettenpapier kann mit den erfindungsgemäßen Naturstoffen in verkapselter oder unverkapselter Form in an sich bekannter Weise versehen werden, wobei hierfür sowohl ein- als auch zwei- lagige Cigarettenpapiere geeignet sind. Im letzteren Fall wird vorzugsweise die innen liegende Tabakstrangumhüllung, welche auch netzartig oder hochporös (10 - 20.000 CORESTA) ausgebildet sein kann, mit den erfindungsgemäßen Substanzen versehen. Diese netzartige innere Tabakstrangumhüllung kann überwiegend oder zur Gänze auch aus geeignetem, antioxidativ wirkenden Lignin enthal¬ tendem Holzschliff gefertigt werden, ebenso zumindest anteilig der Fasergehalt ansonsten üblicher Cigarettenpapiere aus geeig¬ netem ungebleichten ligninhaltige Holzschliff bestehen. Schließlich kann auch der im Bereich der Cigarettennaht zur Verklebung der Tabakstrangumhüllung eingesetzte Leim die erfin¬ dungsgemäßen Naturstoffe in flüssiger oder feingemahlener Form beinhalten. Hierbei hat sich gezeigt, daß die technischen Eigen- Schäften derart behandelter Leime sogar verbessert werden kön¬ nen.The cigarettes paper can be provided with the natural substances according to the invention in encapsulated or unencapsulated form in a manner known per se, both single-layer and two-layer cigarette papers being suitable for this. In the latter case, the inner tobacco rod wrapper, which can also be network-like or highly porous (10-20,000 CORESTA), is preferably provided with the substances according to the invention. This net-like inner tobacco rod wrapping can be made predominantly or entirely from suitable wood pulp containing lignin which has an antioxidative effect, and the fiber content of otherwise customary cigarette papers can also consist at least partly of suitable unbleached wood pulp containing lignin. Finally, the glue used in the area of the cigarette seam to glue the tobacco rod casing can also contain the natural substances according to the invention in liquid or finely ground form. It has been shown here that the technical properties of glues treated in this way can even be improved.
Nach dem Grundgedanken der Erfindung wird beim Konsumieren bzw. Abrauchen des erfindungsgemäßen Tabakerzeugnisses dessen Haupt- stromrauch mit den an sich bekannten antioxidativ wirkenden Naturstoffen angereichert, wodurch bewirkt wird, daß die durch den Hauptstromrauch freigesetzten antimutagenen Substanzen nähe¬ rungsweise zeitgleich mit den potentiellen Schadstoffen des Hauptstromrauches dem Organismus am Ort der Verstoffwechselung zur Verfügung stehen und somit spontan eine mögliche mutagene Wirkung der unerwünschten kritischen Substanzen weitgehend kom¬ pensiert wird. Dies bedeutet, daß bei einer vergleichsweise geringen Menge an antimutagen wirkenden Substanzen die gleiche Wirkung erzeugt wird, als wenn nachträglich eine entsprechend größere Menge dieser Substanzen dem Organismus zur Verfügung gestellt würde.According to the basic idea of the invention, when the tobacco product according to the invention is consumed or smoked, its mainstream smoke is enriched with the natural substances known to have an antioxidative effect, with the result that the antimutagenic substances released by the mainstream smoke are approximately at the same time as the potential pollutants of the mainstream smoke are available to the organism at the site of metabolism and thus a possible mutagenic effect of the undesirable critical substances is largely largely compensated. This means that with a comparatively small amount of substances having an anti-mutagen effect, the same effect is produced as if a correspondingly larger amount of these substances were subsequently made available to the organism.
Eine wesentliche Voraussetzung für den praxisbezogenen Einsatz der erfindungsgemäß verwendeten Naturstoffe ist deren ausrei- chender Übergang in den Hauptstromrauch. Experimentelle Befunde haben ergeben, daß diese Voraussetzung von den eingesetzten Naturstoffen erfüllt wird (vgl. Beispiel 4). Zudem hat sich gezeigt, daß der Übergang in den Hauptstromrauch von in Pflan¬ zenteilen inkorporierten erfindungsgemäßen Naturstoffen - bei- spielsweise das Tabakblatt-eigene Scopoletin oder das Piment¬ blatt-eigene Eugenol - noch erheblich begünstigt werden kann durch die Behandlung der entsprechenden Pflanzenteile nach einem der bekannten Bläh- oder Expansionsverfahren, vorzugsweise nach dem sogenannten INCOM - Verfahren der Anmelderin gemäß den Pa- tentschriften DE-PS 29 03 300, DE-PS 31 19 330 und DE-PS 34 14 625. Hierbei werden relevante Inhaltsstoffe der Pflanzenteile "aufgeschlossen", d.h. sie können besonders leicht von auch nur geringen Mengen an Hauptstromrauch transferiert werden.An important prerequisite for the practical use of the natural substances used according to the invention is their sufficient transition to the mainstream smoke. Experimental results have shown that this requirement is met by the natural products used (cf. Example 4). In addition, it has been shown that the transition into the main stream smoke of natural substances according to the invention incorporated in plant parts - for example the tobacco leaf-own scopoletin or the pimento leaf-own eugenol - can still be considerably favored by treating the corresponding plant parts after one the known blowing or expansion process, preferably according to the so-called INCOM process of the applicant according to the patent specifications DE-PS 29 03 300, DE-PS 31 19 330 and DE-PS 34 14 625. Here relevant components of the plant parts "Open-minded", ie they can be easily transferred from even small amounts of main stream smoke.
Überraschenderweise hat sich gezeigt, daß das mutagene Potential der erfindungsgemäß angereicherten Tabakerzeugnisse in signifi¬ kanter Weise reduziert werden konnte. Zum Nachweis dieser anti- mutagenen Wirkung wurde als aussagekräftiger Schnelltest der Ames-Test durchgeführt (a.a.O.).Surprisingly, it has been shown that the mutagenic potential of the tobacco products enriched according to the invention could be significantly reduced. To prove this anti-mutagenic effect, the Ames test was carried out as a meaningful rapid test (op. Cit.).
Das Testprinzip besteht im wesentlichen darin, daß Histidin- auxotrophe (his") Indikatorbakterien der Art Salmonella tvphimu- rium unter dem Einfluß mutagen wirkender Stoffe in ihre proto- trophe Form (his+) rückmutieren. Die Durchführung des Arnes-Tests, ohne bzw. mit "S 9-Aktivierung", erlaubt eine Aussage darüber, ob eine Testsubstanz in ihrer Ausgangsform oder erst nach Ver- stoffwechselung mutagen ist.The test principle essentially consists in the fact that histidine-auxotrophic (his " ) indicator bacteria of the Salmonella tvphimurium species mutate back into their prototrophic form (his + ) under the influence of mutagenic substances. Carrying out the Arnes test without or With "S 9 activation", a statement can be made as to whether a test substance is mutagenic in its initial form or only after metabolism.
Mit diesem Testsystem wurde nachgewiesen, daß die in Lösungs¬ mittel aufgefangene Partikelphase von Tabakrauch nur in ver- stoffwechseltem Zustand mutagen wirkt (vgl. Shigeaki Sato et al. , "Mutagenicity of s oke condensates from cigarettes, cigars and pipe tobacco", Cancer Lett. 3, S. 1-8, 1977).With this test system it was demonstrated that the particle phase of tobacco smoke collected in solvents has a mutagenic effect only in the metabolized state (cf. Shigeaki Sato et al., "Mutagenicity of s oke condensates from cigarettes, cigars and pipe tobacco", Cancer Lett 3, pp. 1-8, 1977).
Es gilt als gesichert, daß die meisten Substanzen mit antimuta- gener Wirksamkeit im Ames-Test im menschlichen Organismus eine protektive Wirkung ausüben bzw. zur Stärkung des körpereigenen Abwehrsystems beitragen können (vgl. z.B. B.N. Arnes, "Dietary Carcinogens and Anticarcinogens", SCIENCE, Bd. 221, S. 1256 - 1264, 1983). Die im menschlichen Organismus mögliche Bildung von toxischen Stoffwechselprodukten aus Rauchinhaltsstoffen und die gezielte Verminderung der daraus resultierenden mutagenen Wir¬ kung durch Zusatz von Antimutagenen kann im Ames-Test simuliert werden.It is certain that most substances with antimutagenic activity in the Ames test have a protective effect in the human organism or can contribute to strengthening the body's defense system (see, for example, BN Arnes, "Dietary Carcinogens and Anticarcinogens", SCIENCE, 221, pp. 1256-1264, 1983). The possible formation of toxic metabolic products from smoke constituents in the human organism and the targeted reduction of the resulting mutagenic effect by adding antimutagens can be simulated in the Ames test.
Das erfindungsgemäß vorgeschlagene Tabakerzeugnis weist gegen¬ über den herkömmlichen Produkten ein stark vermindertes Risiko- potential auf, da die verwendeten Naturstoffe ihre antioxidati¬ ven Eigenschaften auf eine Vielzahl unerwünschter Substanzen ausüben und ihre Wirkungen am Ort der Verstoffwechselung entfal¬ ten.The tobacco product proposed according to the invention has a greatly reduced risk compared to conventional products. potential, since the natural substances used exert their antioxidative properties on a large number of undesirable substances and their effects develop at the point of metabolism.
Die Erfindung wird anhand der nachfolgenden Beispiele und der Figuren 1 bis 7 näher erläutert.The invention is explained in more detail with reference to the following examples and FIGS. 1 to 7.
Beispiel 1example 1
Zur Vorbereitung des Arnes-Tests wurden 20 unten näher spezifi¬ zierte Cigaretten unter den üblichen Normbedingungen (ISO 4387, Zugvolumen 35 ml, Zugzeit 2 Sekunden und Zugpause 58 Sekunden) maschinell abgeraucht. Die sogenannte Partikelphase des Haupt¬ stromrauches (Rauchkondensat) wurde auf einem Cambridge-Glasfa¬ serfilter niedergeschlagen, mit 20 ml Dimethylsul oxid abgelöst und bis zum Gebrauch bei -20°C gelagert. Die nicht ventilierten Filtercigaretten (Format 100 x 7,9 mm, Strang 75 mm lang, Filter 25 mm lang) besaßen ein Stranggewicht von 945 ± 10 mg (Virginia- Mischung), die abgerauchte Tabakmenge lag bei 800 mg. Das 48 mg schwere Cigarettenpapier besaß eine Porosität von 24 Coresta, das Filtergewicht lag bei gerundet 180 mg, das Filtermaterial bestand aus handelsüblichen Celluloseacetatfasern (3,0 Y / 35000), der Härter war Triacetin (ca. 7 %).To prepare the Arnes test, 20 cigarettes specified below were machine-smoked under the usual standard conditions (ISO 4387, train volume 35 ml, train time 2 seconds and train pause 58 seconds). The so-called particle phase of the main stream smoke (smoke condensate) was deposited on a Cambridge glass fiber filter, detached with 20 ml of dimethyl sulfoxide and stored at -20 ° C. until used. The non-ventilated filter cigarettes (format 100 x 7.9 mm, line 75 mm long, filter 25 mm long) had a line weight of 945 ± 10 mg (Virginia mixture), the amount of tobacco smoked was 800 mg. The 48 mg heavy cigarette paper had a porosity of 24 coresta, the filter weight was around 180 mg, the filter material consisted of commercially available cellulose acetate fibers (3.0 Y / 35000), the hardener was triacetin (approx. 7%).
Beispiel 2Example 2
Zur Bestimmung der mutagenen Wirkung wurde der Ames-Test (a.a.O.) in der Version "plate incorporation" wie nachfolgend beschrieben durchgeführt.To determine the mutagenic effect, the Ames test (op. Cit.) Was carried out in the "plate incorporation" version as described below.
Zu jeweils 2 ml eines bei 43 °C temperierten Weichagars wurden 0,1 ml Übernachtkultur von Salmonella typhimurium. Stamm TA 98,0.1 ml overnight culture of Salmonella typhimurium was added to each 2 ml of a soft agar tempered at 43 ° C. Strain TA 98,
0,05 ml abgestuft verdünnte Rauchkondensat-Lösung gemäß Beispiel 1 und 0,5 ml S 9-Mix (Aktivierungssystem) , bestehend aus 50 μl durch Zentrifugieren von Leberhomogenat Aroclor-vorbehandelter Ratten bei 9.000 g erhaltenem Überstand; 0,76 mg Glucose-6- Phosphat; 1,57 mg NADP; 0,81 mg MgCl2 6 H20; 1,23 mg KC1 in Phosphatpuffer pH 7,4, pipettiert. Nach kurzem Durchmischen wurden die Testansätze in Petrischalen gleichmäßig auf einen Agar verteilt, der nur das Wachstum der his+-Rückmutanten zuläßt. Die Petrischalen wurden nachfolgend 48 Stunden lang bei 37 °C im Dunkeln inkubiert. Nach Ablauf der Inkubationszeit wurden die aus einzelnen his+-rückmutierten Bakterien entstandenen Kolonien ausgezählt. Die Mutationshäufigkeit ist das Maß für die mutagene Aktivität.0.05 ml graded diluted smoke condensate solution according to the example 1 and 0.5 ml S 9 mix (activation system), consisting of 50 μl by centrifuging liver homogenate Aroclor-pretreated rats with 9,000 g of supernatant obtained; 0.76 mg glucose-6-phosphate; 1.57 mg NADP; 0.81 mg MgCl 2 6 H 2 0; 1.23 mg KC1 in phosphate buffer pH 7.4, pipetted. After a short mixing, the test batches in petri dishes were evenly distributed on an agar which only allowed the growth of the his + back mutants. The petri dishes were subsequently incubated at 37 ° C in the dark for 48 hours. After the incubation period, the colonies formed from individual his + back-mutated bacteria were counted. The mutation frequency is the measure of the mutagenic activity.
Aus den in der nachfolgenden Tabelle 4 dargestellten Ergebnissen ist ersichtlich, daß die im Rauchkondensat enthaltenen Stoffe ihre mutagene Wirkung erst nach ihrer Verstoffwechselung entfal¬ ten. It can be seen from the results shown in Table 4 below that the substances contained in the smoke condensate only develop their mutagenic effect after they have been metabolized.
Tabelle 4Table 4
Ausgezählte TA 98-Kolonien in Abhängigkeit zur eingesetzten KondensatmengeCounted TA 98 colonies depending on the amount of condensate used
(Mittelwerte aus Dreifachbestimmungen)(Mean values from triplicate determinations)
Menge Rauchkondensat S9-Akli vierung ausgezählte Kolonien induzierte KolonienAmount of smoke condensate S9 treatment Counted colonies induced colonies
(μg pro Platte)(μg per plate)
0 ohne 41 -0 without 41 -
120 ohne 43 2120 without 43 2
240 ohne 40 -1240 without 40 -1
360 ohne 35 -6360 without 35 -6
0 mit 50 -0 with 50 -
120 mit 216 166120 with 216 166
240 mit 441 391240 with 441 391
360 mit 581 531360 with 581 531
Beispiel 3Example 3
Die Bewertung von erfindungsgemäßen Substanzen hinsichtlich ihrer antimutagenen Wirkungen erfolgte mit dem in Beispiel 2 beschriebenen Testsystem, indem den Testansätzen mit den ver¬ schiedenen Kondensatmengen nun zusätzlich abgestufte Dosierungen der betreffenden Substanzen zugesetzt wurden. Dabei wurde si¬ chergestellt, daß in einem für die Bakterien nicht toxischen Konzentrationsbereich gearbeitet wurde.The evaluation of substances according to the invention with regard to their antimutagenic effects was carried out using the test system described in Example 2, in that graduated dosages of the substances in question were now additionally added to the test batches with the various amounts of condensate. It was ensured that the concentration was not toxic to the bacteria.
In den Figuren 1 bis 6 sind beispielhaft die Ergebnisse von einigen der erfindungsgemäßen Substanzen mit antimutagener Wir¬ kung auf Rauchkondensat dargestellt.The results of some of the substances according to the invention having an antimutagenic effect on smoke condensate are shown by way of example in FIGS. 1 to 6.
Die Ergebnisse zeigen, daß die durch die im Rauchkondensat ent¬ haltenen Schadstoffe verursachte Mutationshäufigkeit und damit das Gefährdungspotential durch die zugesetzten Naturstoffe ent¬ scheidend vermindert werden konnten.The results show that the frequency of mutations caused by the pollutants contained in the smoke condensate and thus the risk potential from the added natural substances could be decisively reduced.
Beispiel 4Example 4
Die zuzusetzenden Naturstoffe unterscheiden sich erheblich be¬ züglich ihrer Schmelz- und Siedepunkte (vgl. Tabelle 1). Um nachzuweisen, daß auch dem Tabak zugesetzte Substanzen in den Tabakrauch übergehen, die nicht destillierbar sind, wurde fol¬ gender Versuch durchgeführt:The natural substances to be added differ considerably with regard to their melting and boiling points (cf. Table 1). In order to demonstrate that substances added to tobacco which cannot be distilled are also converted into tobacco smoke, the following experiment was carried out:
Scopoletin (7-Hydroxy-6-methoxycumarin) mit einem Schmelzpunkt von 205 °C, ohne Siedepunkt, ist als natürlicher Pflanzenin- haltsstoff in Virginiatabaken in einer Konzentration von etwa 300 ppm enthalten. Um den Übergang von zugesetztem Scopoletin in den Hauptstromrauch nachzuweisen, wurden drei Versionen von Versuchscigaretten auf Basis des gleichen Cigaretten-Loses wie in Beispiel 1 hergestellt. Dabei wurde auf bekannte Weise der Tabak von 60 Filtercigaretten gemäß Beispiel 1 aus diesen mit¬ tels Druckluft ausgeblasen, aufgefangen, gedrittelt, zwei Drit¬ tel mit dem Naturstoff aviviert (der Vergleich nur mit Ethanol) und in 60 gleichen Anteilen den ausgeblasenen, in drei Lose unterteilten 3 x 20 Filterhülsen mittels einer handelsüblichen Tabakstopfmaschine für Filtercigarettenhülsen wieder zugefügt, wobei sich allerdings das Stranggewicht der derart gefertigten Filtercigaretten geringfügig verringerte. Dabei wurde die Kon¬ zentration an Scopoletin des Tabaks durch Aufsprühen einer etha- nolischen Lösung von Scopoletin auf den Cigaretten-Tabak von ur- sprünglich 330 ppm auf 630 ppm bzw. 5.330 ppm erhöht. Die herge¬ stellten Cigaretten wurden wie in Beispiel 1 beschrieben abge¬ raucht, wobei das aufgefangene Rauchkondensat in Methanol gelöst wurde. Die Filterhülsen-Design Daten entsprachen denen des Bei¬ spiels 1, das Stranggewicht verringerte sich auf 930 ± 20 mg, die abgerauchte Tabakmenge lag bei 785 mg. Die analytische Bestimmung des Scopoletins erfolgte mittels HPL unter folgenden Bedingungen:Scopoletin (7-hydroxy-6-methoxycoumarin) with a melting point of 205 ° C, without boiling point, is contained as a natural plant substance in virginia tobacco in a concentration of about 300 ppm. In order to detect the transition from added scopoletin to the mainstream smoke, three versions of experimental cigarettes were produced on the basis of the same lot of cigarettes as in Example 1. In a known manner, the tobacco of 60 filter cigarettes according to Example 1 was blown out of these using compressed air, collected, divided into thirds, two thirds of the natural product (compared only with ethanol) and in 60 equal proportions the blown out, in three Loose divided 3 x 20 filter sleeves were added again using a commercially available tobacco tamping machine for filter cigarette tubes, although the strand weight of the filter cigarettes produced in this way decreased slightly. The concentration of scopoletin in the tobacco was increased by spraying an ethanolic solution of scopoletin on the cigarette tobacco from the original 330 ppm to 630 ppm and 5,330 ppm, respectively. The manufactured cigarettes were smoked as described in Example 1, the smoke condensate collected being dissolved in methanol. The filter sleeve design data corresponded to that of Example 1, the strand weight decreased to 930 ± 20 mg, the amount of tobacco smoked was 785 mg. The analytical determination of scopoletin was carried out using HPL under the following conditions:
Säule: Li Chro CART superspher RP 8, 250-4 (Fa. Merck)Column: Li Chro CART superspher RP 8, 250-4 (Merck)
Fließmittel: Wasser/Methanol/Essigsäure - 85/13/2Plasticizer: water / methanol / acetic acid - 85/13/2
Fließgeschwindigkeit: 1,2 ml/min Betrieb isokratisch bei 45°C Detektor bei 340 nmFlow rate: 1.2 ml / min operation isocratic at 45 ° C detector at 340 nm
Einspritzvolumen: 10 μl ProbeInjection volume: 10 μl sample
In der folgenden Tabelle 5 sind die erhaltenen Versuchsergeb¬ nisse zusammengestellt.The test results obtained are summarized in Table 5 below.
Tabelle 5Table 5
Übergang von Scopoletin in den HauptstromrauchTransition from scopoletin to mainstream smoke
ScopoletinScopoletin
Cigaretten- Konzentration Menge im im Hauptstrom¬ Anteil von der version im Tabak abgerauchten rauch gefundene Menge des abge¬Cigarette concentration Amount of smoke found in the main stream portion of the smoke smoked from the version in tobacco
Tabak Menge rauchten TabaksTobacco crowd smoked tobacco
(ppm) (μg) (μg) (%)(ppm) (μg) (μg) (%)
Vergleich 330 259,1 28,2 10,9Comparison 330 259.1 28.2 10.9
Versuchs¬ 630 494,6 47,6 9,6 mischung 1Experimental 630 494.6 47.6 9.6 mixture 1
Versuchs¬ 5330 4.184,1 331,1 6,2 mischung 2Experimental 5330 4,184.1 331.1 6.2 mixture 2
Abgerauchte Tabakmenge: 785 mg pro CigaretteSmoked amount of tobacco: 785 mg per cigarette
Die Versuche mit Scopoletin, als Vertreter der nichtflüchtige antimutagen wirkenden Substanzen, zeigen, daß die Beaufschlagun des Tabaks mit 300 bzw. 5.000 ppm zu einem StoffÜbergang von 9,6 resp. 6,2% in den Hauptstromrauch geführt hat.The experiments with scopoletin, as a representative of the non-volatile antimutagenic substances, show that the exposure of tobacco with 300 or 5,000 ppm to a mass transfer of 9.6 or 6.2% in the main electricity smoke.
Beispiel 5Example 5
Die Ergebnisse des nachfolgend beschriebenen Versuches zeigen, daß die in den Rauch übergehenden antioxidativ wirksamen Sub¬ stanzen aus Abmischungen von Schnittabak mit Nelken resp. Zimt¬ stangen, sowie die Beaufschlagung mit reinem Eugenol, die muta- gene Wirkung so entstandenen Rauchkondensates vermindern.The results of the experiment described below show that the antioxidative substances which pass into the smoke from mixtures of cut tobacco with cloves or. Cinnamon sticks and the exposure to pure eugenol reduce the mutagenic effect of smoke condensates.
Es wurden fünf Versionen Filtercigaretten, die sich bei gleicher Tabak-Basismischung in der Zusammensetzung der Endmischung gemäß Tabelle 6 unterschieden, in gleicher Ausstattung und gleichem Cigarettengewicht (940 mg) hergestellt. Die eingesetzten Nelken bzw. Zimtstangen wurden vor dem Mischen mit Tabak mit Dampf aufgefeuchtet, gewalzt und geschnitten. Die Aufgabe des Eugenols erfolgte in 20%iger ethanolischer Lösung, wobei der Alkohol nach der Behandlung quantitativ verdunstet wurde. Five versions of filter cigarettes, which differed in the composition of the final mixture according to Table 6 with the same tobacco base mixture, were produced with the same equipment and the same cigarette weight (940 mg). The cloves or cinnamon sticks used were dampened with steam, rolled and cut before mixing with tobacco. The eugenol was applied in 20% ethanol solution, the alcohol evaporating quantitatively after the treatment.
Tabelle 6Table 6
Schnittabak mit Zusätzen von Nelken, Zimtstaπgen und EugenolCut tobacco with additions of cloves, cinnamon sticks and eugenol
Zusammensetzung der SchnittabakmischungComposition of the cut tobacco mixture
Mischungmixture
Tabak Nelken Zimtstangen zugesetztes (% Tτ. (% Tr.)^ (% Tτ. reines Eugenol Tobacco cloves cinnamon sticks added (% Tτ. (% Tr.) ^ (% Tτ. Pure eugenol
1 70 30 _. ...1 70 30 _. ...
2 70 — 30 ...2 70 - 30 ...
3 70 15 15 ...3 70 15 15 ...
4 94,9 — ... 5.11'4 94.9 - ... 5.1 1 '
5 100 — — ...5 100 - - ...
1) Die hier zugesetzte Eugenolmenge ist äquivalent der in den Nelken von Mischung 1 enthaltenen 1) The amount of eugenol added here is equivalent to that contained in the cloves of mixture 1
Eugenolmenge. *■' % Tr. = Gewichtsprozent, bezogen auf das Trockengewicht.Amount of eugenol. * ■ '% Tr. = Percent by weight, based on the dry weight.
Die Versuchscigaretten wurden unter Normbedingungen abgeraucht (siehe Beispiel 1) . Die daraus resultierenden Rauchkondensatlö- sungen wurden mit dem Ames-Test gemäß Beispiel 2 untersucht, und zwar in der Ausführungsform "mit S9-Aktivierung" . Zur Bewertung der Mutagenität wurden gleiche Rauchkondensatmengen eingesetzt und die Ergebnisse auf den unbehandelten Vergleich = 100 % bezo¬ gen.The test cigarettes were smoked under standard conditions (see example 1). The resulting smoke condensate solutions were examined with the Ames test according to Example 2, specifically in the embodiment "with S9 activation". To evaluate the mutagenicity, the same amounts of smoke condensate were used and the results relate to the untreated comparison = 100%.
In Figur 7 sind die Versuchsergebnisse graphisch dargestellt. Die Mutagenität des Rauchkondensates der Mischung 1 wurde auf 55,5 % der Wirkung des Vergleichs vermindert, was sich mit der in den Nelken enthaltenen Eugenolmenge erklären läßt. Die einge- setzten Nelken hatten einen Eugenolgehalt von 17,0 %. Im Gegen¬ satz dazu kann die überraschende Verminderung der Mutagenität des Rauchkondensates der Mischung 2 auf 65,3 % nicht allein mit den enthaltenen Mengen an Zimtaldehyd und Eugenol erklärt wer¬ den. The test results are shown graphically in FIG. The mutagenicity of the smoke condensate of mixture 1 was reduced to 55.5% of the effect of the comparison, which can be explained by the amount of eugenol contained in the cloves. The cloves used had an eugenol content of 17.0%. In contrast, the surprising reduction in mutagenicity can of the smoke condensate of mixture 2 to 65.3% cannot be explained solely by the amounts of cinnamaldehyde and eugenol contained.

Claims

Patentansprüche Claims
1. Rauchbares Erzeugnis aus Tabak und/oder einem anderen rauch¬ baren Material, umfassend antioxidativ wirkende Naturstoffe und/oder naturidentische Syntheseprodukte derselben, dadurch gekennzeichnet, daß die Naturstoffe und naturidentischen Syntheseprodukte derselben ausgewählt sind aus:1. Smokable product made of tobacco and / or another smokable material, comprising natural substances having an antioxidative effect and / or synthesis products of the same nature, characterized in that the natural products and synthesis products of the same nature are selected from:
(a) Hydroxyzimtsäuren, deren Estern und Depsiden;(a) hydroxycinnamic acids, their esters and depsides;
(b) von Hydroxyzimtsäuren ableitbaren pflanzlichen Pheno¬ len;(b) vegetable phenols derived from hydroxycinnamic acids;
(c) Polymeren der Hydroxyzimtalkohole;(c) polymers of the hydroxycinnamic alcohols;
(d) Kombinationen weiterer Naturstoffe pflanzlichen Ur¬ sprungs, die antimutagene und aromatisierende Eigen¬ schaften aufweisen, mit antioxidativ wirkenden Vita¬ minen, ihren Vorstufen und/oder Derivaten;(d) combinations of other natural substances of vegetable origin, which have antimutagenic and aromatizing properties, with antioxidant vitamins, their precursors and / or derivatives;
(e) Komplexen antioxidativ wirkender Vitamine mit eukary- ontischen Zellkulturen.(e) complexes of antioxidant vitamins with eukaryotic cell cultures.
2. Rauchbares Erzeugnis nach Anspruch 1, dadurch gekennzeich¬ net, daß die Hydroxyzimtsäuren p-Cumarsäure, Kaffeesäure und Ferulasäure sind.2. Smokable product according to claim 1, characterized gekennzeich¬ net that the hydroxycinnamic acids are p-cumaric acid, caffeic acid and ferulic acid.
3. Rauchbares Erzeugnis nach Anspruch 1 oder 2, dadurch gekenn¬ zeichnet, daß die Ester der Hydroxyzimtsäuren deren Methyl- und Ethylester sind.3. Smokable product according to claim 1 or 2, characterized gekenn¬ characterized in that the esters of hydroxycinnamic acids are their methyl and ethyl esters.
4. Rauchbares Erzeugnis nach Anspruch 1 oder 2, dadurch gekenn¬ zeichnet, daß die Depside der Hydroxyzimtsäuren aus deren Verbindungen mit Fruchtsäuren und Chinasäure bestehen.4. Smokable product according to claim 1 or 2, characterized gekenn¬ characterized in that the depside of hydroxycinnamic acids consist of their compounds with fruit acids and quinic acid.
5. Rauchbares Erzeugnis nach Anspruch 4, dadurch gekennzeich¬ net, daß die Depside Chlorogensäuren sind. 5. Smokable product according to claim 4, characterized gekennzeich¬ net that the deposits are chlorogenic acids.
6. Rauchbares Erzeugnis nach Anspruch 1, dadurch gekennzeich¬ net, daß die von Hydroxyzimtsäuren ableitbaren pflanzlichen Phenole Umbelliferon, Aesculetin, Scopoletin, Curcumin, Ellagsäure und Dihydrokaffeesäure sind.6. Smokable product according to claim 1, characterized gekennzeich¬ net that the vegetable phenols derived from hydroxycinnamic acids are umbelliferone, aesculetin, scopoletin, curcumin, ellagic acid and dihydrocaffeic acid.
7. Rauchbares Erzeugnis nach Anspruch 1, dadurch gekennzeich¬ net, daß die Hydroxyzimtalkohole p-Coumarylalkohol, Conife- rylalkohol und Sinapylalkohol sind.7. Smokable product according to claim 1, characterized gekennzeich¬ net that the hydroxycinnamic alcohols are p-coumaryl alcohol, coniferyl alcohol and sinapyl alcohol.
8. Rauchbares Erzeugnis nach Anspruch 1, dadurch gekennzeich¬ net, daß die weiteren Naturstoffe pflanzlichen Ursprungs Vanillin, Äthylvanillin, Zimtaldehyd, Anisaldehyd, Cumarin, 6-Methylcumarin, Eugenol, Jasminaldehyd, Anethol, p-Anisyl- aceton, Limonen, Zimt und Zimtextrakt sind.8. Smokable product according to claim 1, characterized gekennzeich¬ net that the other natural substances of plant origin vanillin, ethyl vanillin, cinnamaldehyde, anisaldehyde, coumarin, 6-methylcoumarin, eugenol, jasmine aldehyde, anethole, p-anisyl acetone, limonene, cinnamon and cinnamon extract are.
9. Rauchbares Erzeugnis nach Anspruch 1, dadurch gekennzeich¬ net, daß die Naturstoffe aus der Gruppe der antioxidativ wirkenden Vitamine Ascorbinsäure, ß-Carotin, Retinol und α- Tocopherol sowie Derivate derselben sind.9. Smokable product according to claim 1, characterized gekennzeich¬ net that the natural substances from the group of antioxidant vitamins ascorbic acid, ß-carotene, retinol and α-tocopherol and derivatives thereof.
10. Rauchbares Erzeugnis nach Anspruch 9, dadurch gekennzeich¬ net, daß die Ascorbinsäure in Form von Ascorbinsäure-Pal- mitat oder Ascorbigen vorliegt.10. Smokable product according to claim 9, characterized gekennzeich¬ net that the ascorbic acid is in the form of ascorbic acid palmitate or ascorbigen.
11. Rauchbares Erzeugnis nach Anspruch 1, dadurch gekennzeich¬ net, daß die mit eukaryontischen Zellkulturen komplexierten antioxidativ wirkenden Vitamine ß-Carotin, Retinol und α- Tocopherol sowie Derivate derselben sind.11. A smokable product according to claim 1, characterized in that the antioxidative vitamins complexed with eukaryotic cell cultures are β-carotene, retinol and α-tocopherol and derivatives thereof.
12. Rauchbares Erzeugnis nach den Ansprüchen 1 bis 11, dadurch gekennzeichnet, daß die antioxidativ wirkenden Naturstoffe und/oder naturidentischen Syntheseprodukte derselben einzeln oder in Kombination enthalten sind. 12. Smokable product according to claims 1 to 11, characterized in that the antioxidative natural substances and / or nature-identical synthesis products thereof are contained individually or in combination.
13. Rauchbares Erzeugnis nach den Ansprüchen 1 bis 12, dadurch gekennzeichnet, daß es 0,1 Promille bis 25 Gew.-% der antio¬ xidativ wirkenden Naturstoffe enthält.13. Smokable product according to claims 1 to 12, characterized in that it contains 0.1 per mille to 25 wt .-% of the antioxidative natural substances.
14. Rauchbares Erzeugnis nach Anspruch 13, dadurch gekennzeich¬ net, daß es 1 bis 5 Gew.-% der antioxidativ wirkenden Natur¬ stoffe enthält.14. Smokable product according to claim 13, characterized gekennzeich¬ net that it contains 1 to 5 wt .-% of the antioxidative natural substances.
15. Rauchbares Erzeugnis nach einem der Ansprüche 1 bis 14, da¬ durch gekennzeichnet, daß es eine Cigarette mit oder ohne Filter ist.15. Smokable product according to one of claims 1 to 14, characterized in that it is a cigarette with or without a filter.
16. Rauchbares Erzeugnis nach einem der Ansprüche 1 bis 14, dadurch gekennzeichnet, daß es ein Cigarillo mit oder ohne Filter ist.16. Smokable product according to one of claims 1 to 14, characterized in that it is a cigarillo with or without a filter.
17. Rauchbares Erzeugnis nach einem der Ansprüche 1 bis 14, dadurch gekennzeichnet, daß es eine Tabakpatrone mit oder ohne Filter ist.17. Smokable product according to one of claims 1 to 14, characterized in that it is a tobacco cartridge with or without a filter.
18. Rauchbares Erzeugnis nach einem der Ansprüche 1 bis 14, dadurch gekennzeichnet, daß es Rauchtabak in Form von Fein¬ schnitt oder Pfeifentabak ist.18. Smokable product according to one of claims 1 to 14, characterized in that it is smoking tobacco in the form of Fein¬ cut or pipe tobacco.
19. Rauchbares Erzeugnis nach den Ansprüchen 15 bis 17, dadurch gekennzeichnet, daß der Filter 0,1 bis 50 Gew. % an den antioxidativ wirkenden Naturstoffen und/ oder naturidenti¬ schen Syntheseprodukten derselben gemäß einem der Ansprü¬ che 1 bis 12 enthält.19. Smokable product according to claims 15 to 17, characterized in that the filter contains 0.1 to 50% by weight of the antioxidative natural substances and / or nature-identical synthesis products thereof according to one of claims 1 to 12.
20. Rauchbares Erzeugnis nach Anspruch 19, dadurch gekennzeich¬ net, daß der Filter 1 bis 20 Gew.-% an den antioxidativ wirkenden Naturstoffen und/oder naturidentischen Synthese¬ produkten derselben gemäß einem der Ansprüche 1 bis 12 ent¬ hält. 20. Smokable product according to claim 19, characterized in that the filter contains 1 to 20% by weight of the antioxidative natural substances and / or nature-identical synthesis products thereof according to one of claims 1 to 12.
21. Rauchbares Erzeugnis nach einem der Ansprüche 15 bis 17 bzw. 19 und 20, dadurch gekennzeichnet, daß der Filter ein Kam¬ merfilter mit oder ohne Filterventilierung ist.21. Smokable product according to one of claims 15 to 17 or 19 and 20, characterized in that the filter is a chamber filter with or without filter ventilation.
22. Rauchbares Erzeugnis nach einem der Ansprüche 15 bis 17 bzw. 19 und 20, dadurch gekennzeichnet, daß der Filter ein han¬ delsüblicher Celluloseacetatfaserfilter mit oder ohne Fil¬ terventilierung ist.22. Smokable product according to one of claims 15 to 17 or 19 and 20, characterized in that the filter is a commercially available cellulose acetate fiber filter with or without filter ventilation.
23. Rauchbares Erzeugnis nach einem der Ansprüche 15 bis 17 bzw. 19 und 20, dadurch gekennzeichnet, daß der Filter ein han¬ delsüblicher Cellulose-Wirrfaservlies-Filter mit oder ohne Filterventilierung ist.23. Smokable product according to one of claims 15 to 17 or 19 and 20, characterized in that the filter is a commercially available cellulose random-fiber fleece filter with or without filter ventilation.
24. Rauchbares Erzeugnis nach einem der Ansprüche 15 bis 17 bzw. 19 und 20, dadurch gekennzeichnet, daß der Filter ein Mehr¬ fachfilter, vorzugsweise Doppelfilter mit einem höheren strangseitigen Zugwiderstand und einem niedrigeren mundsei- tigen Zugwiderstand mit oder ohne Filterventilierung ist und einen Gesamtfilter-Wirkungsgrad von 80 - 99% aufweist.24. Smokable product according to one of claims 15 to 17 or 19 and 20, characterized in that the filter is a Mehr¬ multiple filter, preferably double filter with a higher strand-side draw resistance and a lower mouth-side draw resistance with or without filter ventilation and an overall filter -Efficiency of 80-99%.
25. Rauchbares Erzeugnis nach den Ansprüchen 15 bis 17, dadurch gekennzeichnet, daß das Cigarettenpapier 0,1 bis 50 Gew.-% an den antioxidativ wirkenden Naturstoffen und/ oder natur¬ identischen Syntheseprodukten derselben gemäß einem der Ansprüche 1 bis 12 enthält.25. Smokable product according to claims 15 to 17, characterized in that the cigarette paper contains 0.1 to 50% by weight of the antioxidative natural substances and / or natur¬ identical synthesis products thereof according to one of claims 1 to 12.
26. Rauchbares Erzeugnis nach einem der vorhergehenden Ansprü¬ che, dadurch gekennzeichnet, daß das rauchbare Basis-Materi¬ al Mischungen aus Lamina-Tabaken oder Lamina-Tabak und Fo¬ lientabak sind.26. Smokable product according to one of the preceding claims, characterized in that the smokable base materials are mixtures of lamina tobacco or lamina tobacco and film tobacco.
27. Rauchbares Erzeugnis nach einem der vorhergehenden Ansprü¬ che, dadurch gekennzeichnet, daß das rauchbare Material 0,1 Promille bis 25 Gew.-% an den antioxidativ wirkenden Natur- Stoffen und/ oder naturidentischen Syntheseprodukten dersel¬ ben gemäß einem der Ansprüche 1 bis 12 enthält.27. Smokable product according to one of the preceding claims, characterized in that the smokable material contains 0.1 per mille to 25% by weight of the antioxidative natural Contains substances and / or nature-identical synthetic products thereof according to one of claims 1 to 12.
28. Rauchbares Erzeugnis nach einem der vorhergehenden Ansprü¬ che, dadurch gekennzeichnet, daß das rauchbare Material eine tabakfreie Mischung aus Pflanzenmaterial ist, welches sich von Huflattich, Pfefferminze, Brennessel, Breitwegerich, Krauseminze, Lavendel, Thymian, Süß- oder Sauerkirschblät¬ tern, Knöterichblättern, Rosenblätter, Pimentblättern oder Zimtrinde ableitet.28. Smokable product according to one of the preceding claims, characterized in that the smokable material is a tobacco-free mixture of plant material which is made from coltsfoot, peppermint, nettle, white plantain, spearmint, lavender, thyme, sweet or sour cherry leaves, Knotweed leaves, rose leaves, allspice leaves or cinnamon bark.
29. Rauchbares Erzeugnis nach den Ansprüchen 26 bis 28, dadurch gekennzeichnet, daß das rauchbare Material eine Kombination aus Tabakmischung und tabakfreier Mischung ist.29. Smokable product according to claims 26 to 28, characterized in that the smokable material is a combination of tobacco mixture and tobacco-free mixture.
30. Verfahren zur Herstellung eines rauchbaren Erzeugnisses in an sich bekannter Weise, bei dem die üblicherweise als Här¬ ter für die den späteren Filter bildenden Celluloseacetatfa¬ sern verwendeten Substanzen zum Teil oder vollständig durch die antioxidativ wirkenden Naturstoffe und/oder naturidenti¬ schen Syntheseprodukte derselben gemäß einem der Ansprüche 1 bis 12 ersetzt werden.30. A process for producing a smokable product in a manner known per se, in which the substances usually used as hardeners for the cellulose acetate fibers forming the subsequent filter are partly or completely produced by the antioxidative natural substances and / or nature-identical synthesis products thereof be replaced according to any one of claims 1 to 12.
31. Verfahren nach Anspruch 30, dadurch gekennzeichnet, daß als Naturstoff Eugenol allein oder als Lösung mit antioxidativ wirksamen Aromastoffen in Kombination mit Vitaminen einge¬ setzt wird.31. The method according to claim 30, characterized in that eugenol is used alone or as a solution with antioxidative flavoring substances in combination with vitamins as the natural substance.
32. Verfahren nach Anspruch 31, dadurch gekennzeichnet, daß die antioxidativ wirksamen Aromastoffe aus Zimtaldehyd, Jasmin¬ aldehyd, Äthylvanillin und/oder 6-Methylcumarin ausgewählt werden.32. The method according to claim 31, characterized in that the antioxidant flavorings are selected from cinnamaldehyde, jasmine aldehyde, ethyl vanillin and / or 6-methylcoumarin.
33. Verfahren nach Anspruch 31, dadurch gekennzeichnet, daß die Vitamine aus α-Tocopherolacetat, Tocopherolsuccinat, Retinol und/oder Retinolpalmitat ausgewählt werden. 33. The method according to claim 31, characterized in that the vitamins are selected from α-tocopherol acetate, tocopherol succinate, retinol and / or retinol palmitate.
EP95917934A 1994-04-19 1995-04-18 Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same Expired - Lifetime EP0756461B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SI9530458T SI0756461T1 (en) 1994-04-19 1995-04-18 Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4416101A DE4416101C2 (en) 1994-04-19 1994-04-19 Tobacco products or tobacco products similar goods with natural substances having an antioxidative effect and process for producing the same
DE4416101 1994-04-19
PCT/EP1995/001452 WO1995028098A1 (en) 1994-04-19 1995-04-18 Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same

Publications (2)

Publication Number Publication Date
EP0756461A1 true EP0756461A1 (en) 1997-02-05
EP0756461B1 EP0756461B1 (en) 2000-11-02

Family

ID=6517522

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95917934A Expired - Lifetime EP0756461B1 (en) 1994-04-19 1995-04-18 Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same

Country Status (27)

Country Link
US (1) US5944026A (en)
EP (1) EP0756461B1 (en)
JP (1) JPH10503082A (en)
KR (1) KR100357665B1 (en)
CN (1) CN1148324A (en)
AT (1) ATE197226T1 (en)
BG (1) BG63420B1 (en)
CA (1) CA2184592A1 (en)
CZ (1) CZ294496A3 (en)
DE (2) DE4416101C2 (en)
DK (1) DK0756461T3 (en)
EE (1) EE9600149A (en)
ES (1) ES2151598T3 (en)
GR (1) GR3035240T3 (en)
HK (1) HK1012873A1 (en)
HU (1) HUT76247A (en)
LV (1) LV11721B (en)
MD (1) MD1976B2 (en)
PL (1) PL177413B1 (en)
PT (1) PT756461E (en)
RO (1) RO117888B1 (en)
RU (1) RU2142729C1 (en)
SI (1) SI0756461T1 (en)
SK (1) SK120496A3 (en)
TW (1) TW272117B (en)
UA (1) UA45336C2 (en)
WO (1) WO1995028098A1 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416101C2 (en) * 1994-04-19 1997-06-12 Reemtsma H F & Ph Tobacco products or tobacco products similar goods with natural substances having an antioxidative effect and process for producing the same
DE19541873A1 (en) * 1995-11-09 1997-05-15 Rhodia Ag Rhone Poulenc Filter cigarette
JPH1192410A (en) * 1997-09-25 1999-04-06 Naohiko Sato Antioxidatively active substance
US6082370A (en) * 1998-02-09 2000-07-04 Rousseau Research, Inc. Cigarette with dry powered Vitamin E
CZ20002901A3 (en) 1998-02-09 2001-08-15 Rousseau Research, Inc. Tobacco articles containing vitamin E
US6615842B1 (en) 1998-02-13 2003-09-09 Cerami Consulting Corp. Methods for removing nucleophilic toxins from tobacco smoke
EE200100445A (en) 1999-02-26 2002-12-16 H.F. & Ph.F. Reemtsma Gmbh Smoked product
MXPA03000125A (en) * 2000-06-26 2004-12-06 Cerami Consulting Corp Methods, agents and devices for removing nucleophilic toxins from tobacco and tobacco smoke.
US20050138910A1 (en) * 2000-10-16 2005-06-30 Peter Rohdewald Air filter with scavenging effect on free radicals in gaseous phase and its method of preparation
EP1411783A2 (en) * 2001-04-09 2004-04-28 George Frederick Enslin A smoker's requisite
KR20030004562A (en) * 2001-07-05 2003-01-15 정진남 Cigarette
US6953040B2 (en) * 2001-09-28 2005-10-11 U.S. Smokeless Tobacco Company Tobacco mint plant material product
HUP0201257A2 (en) * 2002-04-17 2004-05-28 Péter Rozim Filter for filter-tipped cigarette
US20040255965A1 (en) 2003-06-17 2004-12-23 R. J. Reynolds Tobacco Company Reconstituted tobaccos containing additive materials
BRPI0415682A (en) * 2003-11-03 2006-12-19 Us Smokeless Tobacco Co flavored smokeless tobacco and manufacturing methods
JP4588067B2 (en) 2005-03-02 2010-11-24 日本たばこ産業株式会社 Cigarette manufacturing equipment
ATE446022T1 (en) * 2005-07-08 2009-11-15 Ioto Internat Ind E Com De Pro DEVICE FOR REPROCESSING POWDERS OF VEGETABLE ORIGIN
US7795306B2 (en) * 2006-03-03 2010-09-14 Inderjit Kumar Dev Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of NF-κB
US20070207989A1 (en) * 2006-03-03 2007-09-06 Savipu Pharmaceuticals Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases
US7323476B2 (en) * 2006-03-03 2008-01-29 Savipu Pharmaceuticals Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases
US20070243273A1 (en) * 2006-04-12 2007-10-18 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking
US20080017207A1 (en) * 2006-07-18 2008-01-24 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2
US20080187608A1 (en) * 2007-02-05 2008-08-07 Savipu Pharmaceuticals Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases
US20090022821A1 (en) * 2007-07-17 2009-01-22 Inderjit Kumar Dev Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases
KR100903951B1 (en) 2007-07-19 2009-06-25 주식회사 케이티앤지 Cigarette filter containing ascorbic acid derivatives for reducing of free radicals in mainstream smoke
US8360072B2 (en) 2009-10-09 2013-01-29 Philip Morris Usa Inc. Combination treatment of tobacco extract using antioxidants and antioxidant scavengers
CN102495162B (en) * 2011-11-16 2013-11-20 中国烟草总公司郑州烟草研究院 Method for determining content of eugenol in formulated cut tobacco
CN102499437A (en) * 2011-11-20 2012-06-20 红云红河烟草(集团)有限责任公司 Lavender-doped tobacco baking and blending method
KR101475611B1 (en) * 2013-07-01 2014-12-22 이규서 Process for Anti-Stress Cigarette of Aromatheraphy by Functional Flavor
CN103601710B (en) * 2013-11-04 2015-12-02 广东中烟工业有限责任公司 Coumarin derivatives and its preparation method and application
RU2647802C1 (en) * 2014-06-19 2018-03-19 Дайсел Корпорэйшн Tow rag of cigarette filter
RU2586474C1 (en) * 2015-03-27 2016-06-10 Олег Иванович Квасенков Method for production of smoking composition
RU2593074C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593082C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2586472C1 (en) * 2015-03-27 2016-06-10 Олег Иванович Квасенков Method for production of smoking composition
RU2593084C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2586477C1 (en) * 2015-03-27 2016-06-10 Олег Иванович Квасенков Method for production of smoking composition
RU2586478C1 (en) * 2015-03-27 2016-06-10 Олег Иванович Квасенков Method for production of smoking composition
RU2593076C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593086C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593068C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593085C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593081C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2584868C1 (en) * 2015-03-27 2016-05-20 Олег Иванович Квасенков Method for production of smoking composition
RU2593070C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593083C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593073C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593075C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593072C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593071C1 (en) * 2015-03-27 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2583778C1 (en) * 2015-03-27 2016-05-10 Олег Иванович Квасенков Method for production of smoking composition
RU2594139C1 (en) * 2015-04-10 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594141C1 (en) * 2015-04-10 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593077C1 (en) * 2015-04-10 2016-07-27 Олег Иванович Квасенков Method for production of smoking mixture for hookah
RU2586475C1 (en) * 2015-04-10 2016-06-10 Олег Иванович Квасенков Method for production of smoking mixture for hookah
RU2594138C1 (en) * 2015-04-10 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594140C1 (en) * 2015-04-10 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593078C1 (en) * 2015-04-10 2016-07-27 Олег Иванович Квасенков Method for production of smoking mixture for hookah
RU2584856C1 (en) * 2015-04-10 2016-05-20 Олег Иванович Квасенков Method for production of smoking mixture for hookah
RU2593116C1 (en) * 2015-04-10 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593977C1 (en) * 2015-04-10 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2596101C1 (en) * 2015-04-10 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" Method for production of hookah smoking composition
RU2593134C1 (en) * 2015-04-10 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593118C1 (en) * 2015-04-10 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594133C1 (en) * 2015-04-20 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593978C1 (en) * 2015-04-20 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593126C1 (en) * 2015-04-20 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593128C1 (en) * 2015-04-20 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593120C1 (en) * 2015-04-20 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593130C1 (en) * 2015-04-20 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593119C1 (en) * 2015-04-20 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594132C1 (en) * 2015-04-20 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594134C1 (en) * 2015-04-28 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593123C1 (en) * 2015-04-28 2016-07-27 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594136C1 (en) * 2015-04-28 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594135C1 (en) * 2015-04-28 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593969C1 (en) * 2015-04-28 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2594137C1 (en) * 2015-04-28 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593974C1 (en) * 2015-05-20 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2599356C1 (en) * 2015-05-20 2016-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" Method for production of hookah smoking composition
RU2596446C1 (en) * 2015-05-20 2016-09-10 Олег Иванович Квасенков Method for production of hookah smoking composition
RU2593976C1 (en) * 2015-05-20 2016-08-10 Олег Иванович Квасенков Method for production of hookah smoking composition
CN105394808A (en) * 2015-12-17 2016-03-16 立场电子科技发展(上海)有限公司 Atomization liquid for electronic cigarette
US20190192449A1 (en) * 2016-08-31 2019-06-27 Richard Baybutt Composition and use thereof
CN110382777A (en) * 2017-03-02 2019-10-25 Iiw随行送达系统有限公司 Paper products with fragrance and taste
CN107485052A (en) * 2017-08-09 2017-12-19 江西中烟工业有限责任公司 A kind of application of liposoluble vitamin in tobacco mouth rod
SG10201903923SA (en) * 2018-12-31 2020-03-30 Ysq Int Pte Ltd Apparatus and method for producing a filter element

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3339558A (en) * 1966-10-28 1967-09-05 Haskett Barry F Smoking article and filter therefor containing vitamin a
US3861401A (en) * 1973-03-08 1975-01-21 Theodore S Briskin Smokable tobacco substitute material and method
US3943943A (en) * 1974-07-09 1976-03-16 Liggett & Myers Incorporated Cinnamic derivatives as tobacco additives
US3940499A (en) * 1974-09-19 1976-02-24 International Flavors & Fragrances Inc. Food or flavor containing 2,6,6-trimethyl-1-cyclohexen-1-ylacetaldehyde
US4170236A (en) * 1977-06-16 1979-10-09 International Flavors & Fragrances Inc. Isobutyl substituted heterocyclic compounds and uses for augmenting or enhancing the organoleptic properties of smoking compositions
DE3200305C2 (en) * 1982-01-08 1983-11-17 B.A.T. Cigaretten-Fabriken Gmbh, 2000 Hamburg Process for improving the filling capacity of tobacco, in particular tobacco leaf cut
US4516590A (en) * 1982-11-26 1985-05-14 Philip Morris Incorporated Air-cured bright tobacco filler, blends and smoking articles
CH662042A5 (en) * 1983-07-14 1987-09-15 Baumgartner Papiers Sa Cigarette endpiece
HU192213B (en) * 1985-04-29 1987-05-28 Pecsi Dohanygyar Method for producing smoke filter neutralizing the materials injurious the health being in tobacco smoke particularly aldehydes
JPS6214772A (en) * 1985-07-10 1987-01-23 中島 三夫 Innoxious tobacco
US4727058A (en) * 1985-09-26 1988-02-23 International Flavors & Fragrances Inc. Process for preparing natural benzaldehyde and acetaldehyde, natural benzaldehyde and acetaldehyde compositions, products produced thereby and organoleptic utilities therefor
IT8717404A0 (en) * 1987-05-07 1987-05-07 Barbaro Daniele LOCAL DELIVERY SYSTEM, FOR SMOKERS, OF VITAMIN A (OR OTHER RETINOIDS) HAVING CIGARETTE OR CIGAR SMOKE AS ELUENT (SOLVENT AND VEHICLE).
WO1989001301A1 (en) * 1987-08-13 1989-02-23 C.A. Blockers, Inc. Tobacco smoking article
US5000198A (en) * 1989-06-13 1991-03-19 Mituo Nakajima Agent for removing noxious tobacco components
JPH03219860A (en) * 1990-01-25 1991-09-27 Daicel Chem Ind Ltd Filter for tobacco smoke
JPH0523159A (en) * 1991-07-19 1993-02-02 Kikkoman Corp Cigarette filter
US5308874A (en) * 1992-06-26 1994-05-03 Vyrex Corporation Airborne protectants against oxidative tissue damage
JPH0662824A (en) * 1992-08-12 1994-03-08 Kyodo Nyugyo Kk Method for removing free radical from tobacco smoke
DE4244467C2 (en) * 1992-12-24 1996-11-14 Reemtsma H F & Ph Cigarette
DE4416101C2 (en) * 1994-04-19 1997-06-12 Reemtsma H F & Ph Tobacco products or tobacco products similar goods with natural substances having an antioxidative effect and process for producing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9528098A1 *

Also Published As

Publication number Publication date
PL316760A1 (en) 1997-02-03
KR970701507A (en) 1997-04-12
CN1148324A (en) 1997-04-23
ATE197226T1 (en) 2000-11-15
TW272117B (en) 1996-03-11
RU2142729C1 (en) 1999-12-20
LV11721B (en) 1997-12-20
PL177413B1 (en) 1999-11-30
UA45336C2 (en) 2002-04-15
BG63420B1 (en) 2002-01-31
WO1995028098A1 (en) 1995-10-26
HK1012873A1 (en) 1999-09-17
CA2184592A1 (en) 1995-10-26
DK0756461T3 (en) 2000-12-18
BG100927A (en) 1997-07-31
GR3035240T3 (en) 2001-04-30
KR100357665B1 (en) 2003-02-05
DE4416101C2 (en) 1997-06-12
MD1976B2 (en) 2002-08-31
US5944026A (en) 1999-08-31
RO117888B1 (en) 2002-09-30
CZ294496A3 (en) 1997-04-16
EP0756461B1 (en) 2000-11-02
PT756461E (en) 2001-04-30
JPH10503082A (en) 1998-03-24
EE9600149A (en) 1997-04-15
HU9602896D0 (en) 1996-12-30
DE4416101A1 (en) 1995-10-26
SI0756461T1 (en) 2001-04-30
HUT76247A (en) 1997-07-28
ES2151598T3 (en) 2001-01-01
SK120496A3 (en) 1997-03-05
LV11721A (en) 1997-04-20
DE59508825D1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
EP0756461B1 (en) Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same
DE1517242A1 (en) Filter element
DE2931281A1 (en) SMOKABLE MATERIAL AND METHOD FOR THE PRODUCTION THEREOF
EP0081231A2 (en) Process for the production of aromatic substances from a tobacco extract
DE1517297B1 (en) Smoke filters for tobacco products
DE2715469A1 (en) PROCESS FOR INCORPORATING A FLAVOR INTO CELLULOSE SUBSTRATES AND THE PRODUCTS MANUFACTURED THEREOF
AT392878B (en) FILTERS FOR TOBACCO SMOKING AND METHOD FOR THE PRODUCTION THEREOF
EP0069056B1 (en) Process to aromatise tabacco smoke, cigarette end piece to carry out the process, and use of the process
DE1517294A1 (en) Low tar tobacco product and process for its manufacture
DE2246221A1 (en) SMOKING MATERIAL, PROCESS FOR THE PREPARATION THEREOF AND SMOKING PRODUCTS MANUFACTURED THEREFROM
DE69830158T2 (en) REGULATOR FOR TOBACCO TOUCH AROMA
DE2206859A1 (en) Improved taste tobacco products and processes for their manufacture
DE533199C (en) Process for the production of cigarette paper
DE60034968T2 (en) METHOD AND DEVICE FOR REMOVING NUCLEOPHILIC TOXINS FROM TOBACCO AND TOBACCO TOUCH
DD153571A5 (en) METHOD FOR THE TREATMENT OF SMOKING TOBACCO FOR THE DETECTION OF POLLUTION IN SMOKE
DE2559542C3 (en) Cigar filters
DE1517320A1 (en) Additives for tobacco products
DE2738930A1 (en) SMOKING OBJECT
DE1517297C (en) Smoke filters for tobacco products
DE1517311C (en) Process for flavoring tobacco with flavoring substances
DE2120913A1 (en) Process for the production of homogenized tobacco material
DE1757267C3 (en) Process for the production of tobacco foils
DE2313996C3 (en) Water-soluble, easily absorbable snuff and process for its manufacture
DEG0012111MA (en)
DE2313996A1 (en) Water-soluble resorbable snuff powder prepn. - from tobacco aroma extract and inert non-hygroscopic carrier

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961025

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT PAYMENT 961025;SI PAYMENT 961025

17Q First examination report despatched

Effective date: 19970313

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: H.F. & PH.F. REEMTSMA GMBH

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT PAYMENT 19961025;SI PAYMENT 19961025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20001102

REF Corresponds to:

Ref document number: 197226

Country of ref document: AT

Date of ref document: 20001115

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: PATENTANWALTSBUREAU R. A. MASPOLI

Ref country code: CH

Ref legal event code: EP

ITF It: translation for a ep patent filed

Owner name: ING. A. GIAMBROCONO & C. S.R.L.

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20001102

REF Corresponds to:

Ref document number: 59508825

Country of ref document: DE

Date of ref document: 20001207

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: GERMAN

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2151598

Country of ref document: ES

Kind code of ref document: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20010202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010418

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010430

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20010122

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

26 Opposition filed

Opponent name: BRITISH AMERICAN TABACCO (GERMANY) GMBH

Effective date: 20010712

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

NLR1 Nl: opposition has been filed with the epo

Opponent name: BRITISH AMERICAN TABACCO (GERMANY) GMBH

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20020318

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20020321

Year of fee payment: 8

Ref country code: AT

Payment date: 20020321

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20020325

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20020328

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20020405

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20020408

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20020409

Year of fee payment: 8

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: REEMTSMA CIGARETTENFABRIKEN GMBH

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20020426

Year of fee payment: 8

Ref country code: CH

Payment date: 20020426

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20020619

Year of fee payment: 8

NLT2 Nl: modifications (of names), taken from the european patent patent bulletin

Owner name: REEMTSMA CIGARETTENFABRIKEN GMBH

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Free format text: H.F. & PH.F. REEMTSMA GMBH TRANSFER- REEMTSMA CIGARETTENFABRIKEN GMBH

Ref country code: CH

Ref legal event code: NV

Representative=s name: BOVARD AG PATENTANWAELTE

NLS Nl: assignments of ep-patents

Owner name: REEMTSMA CIGARETTENFABRIKEN GMBH

REG Reference to a national code

Ref country code: FR

Ref legal event code: CD

REG Reference to a national code

Ref country code: PT

Ref legal event code: PC4A

Free format text: REEMTSMA CIGARETTENFABRIKEN GMBH DE

Effective date: 20020808

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030418

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030418

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

BERE Be: lapsed

Owner name: *REEMTSMA CIGARETTENFABRIKEN G.M.B.H.

Effective date: 20030430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031101

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031104

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20031101

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20030418

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

LTLA Lt: lapse of european patent or patent extension

Effective date: 20030418

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031231

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031031

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20030419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050418

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: BRITISH AMERICAN TABACCO (GERMANY) GMBH

Effective date: 20010712

PLBD Termination of opposition procedure: decision despatched

Free format text: ORIGINAL CODE: EPIDOSNOPC1

PLBM Termination of opposition procedure: date of legal effect published

Free format text: ORIGINAL CODE: 0009276

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: OPPOSITION PROCEDURE CLOSED

27C Opposition proceedings terminated

Effective date: 20071126